+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 51578

Chapter 51578 contains a list of PDF Full Texts available from EurekaMag.





Safari, D.; Dekker, H.A.Th.; de Jong, B.; Rijkers, G.T.; Kamerling, J.P.; Snippe, H., 2011:
Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization

Araujo, A.C., 2013:
Antibody- and genome-based identification of recent HCV infection

Perez, L.G.; Zolla-Pazner, S.; Montefiori, D.C., 2013:
Antibody-DEPENDENT, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis

Lopus, M., 2011:
Antibody-DM1 conjugates as cancer therapeutics

Isitman, G.; Stratov, I.; Kent, S.J., 2012:
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development

Carlson, B., 2012:
Antibody-Drug Conjugates: Where the Action Is: ADCs - The New Frontier

Desquesnes, M.; Kamyingkird, K.; Pruvot, M.; Kengradomkij, C.; Bossard, G.; Sarataphan, N.; Jittapalapong, S., 2009:
Antibody-ELISA for Trypanosoma evansi: application in a serological survey of dairy cattle, Thailand, and validation of a locally produced antigen

Joller, N.; Weber, S.S.; Oxenius, A., 2011:
Antibody-Fc receptor interactions in protection against intracellular pathogens

Botosoa, E.P.; Maillasson, M.; Mougin-Degraef, M.; Remaud-Le Saëc, P.; Gestin, J-François.; Jacques, Y.; Barbet, J.; Faivre-Chauvet, A., 2011:
Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery

Hombach, A.A.; Abken, H., 2012:
Antibody-IL2 fusion proteins for tumor targeting

Holl, V.; Peressin, M.; Moog, C., 2009:
Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies

Bae, E-Jin.; Lee, H-Jin.; Rockenstein, E.; Ho, D-Hwan.; Park, E-Bi.; Yang, N-Young.; Desplats, P.; Masliah, E.; Lee, S-Jae., 2012:
Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission

Monson, C.F.; Driscoll, L.N.; Bennion, E.; Miller, C.J.; Majda, M., 2009:
Antibody-antigen exchange equilibria in a field of an external force: design of reagentless biosensors

Svensson, O.; Arnebrant, T., 2012:
Antibody-antigen interaction on polystyrene: an in situ ellipsometric study

Kreutz, M.; Giquel, B.; Hu, Q.; Abuknesha, R.; Uematsu, S.; Akira, S.; Nestle, F.O.; Diebold, S.S., 2013:
Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity

Ohk, S.H.; Koo, O.K.; Sen, T.; Yamamoto, C.M.; Bhunia, A.K., 2011:
Antibody-aptamer functionalized fibre-optic biosensor for specific detection of Listeria monocytogenes from food

Bergsma, D.; Chen, S.; Buchweitz, J.; Gerszten, R.; Haab, B.B., 2010:
Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human plasma

Tanegashima, K.; Suzuki, K.; Nakayama, Y.; Hara, T., 2010:
Antibody-assisted enhancement of biological activities of CXCL14 in human monocytic leukemia-derived THP-1 cells and high fat diet-induced obese mice

Bien, C.G., 2012:
Antibody-associated diseases of the gray matter of the CNS: diagnosis and treatment

Briggs, D.; Adams, D.H., 2011:
Antibody-associated rejection in liver transplantation: keep on knocking, and the door will be opened to you

Montefiori, D.; Sattentau, Q.; Flores, J.; Esparza, Jé.; Mascola, J., 2007:
Antibody-based HIV-1 vaccines: recent developments and future directions

Kumeta, M.; Hirai, Y.; Yoshimura, S.H.; Horigome, T.; Takeyasu, K., 2014:
Antibody-based analysis reveals "filamentous vs. non-filamentous" and "cytoplasmic vs. nuclear" crosstalk of cytoskeletal proteins

Bzowska, M.; Mężyk-Kopeć, R.; Próchnicki, T.; Kulesza, Młgorzata.; Klaus, T.; Bereta, J., 2014:
Antibody-based antiangiogenic and antilymphangiogenic therapies to prevent tumor growth and progression

Kerkvliet, E.; Sinnige, N.; Franso, C.; van Ree, R.; van den Hout, R., 2014:
Antibody-based assays for potency determination of mite allergoids and for stability studies of alum-adsorbed mite vaccines

Baxevanis, C.N., 2008:
Antibody-based cancer therapy

Karagiannis, T.C., 2007:
Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies

Chen, W.; Ying, T.; Dimitrov, D.S., 2013:
Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design

Whaley, K.J.; Zeitlin, L., 2014:
Antibody-based concepts for multipurpose prevention technologies

Gutbrodt, K.L.; Casi, G.; Neri, D., 2015:
Antibody-based delivery of IL2 and cytotoxics eradicates tumors in immunocompetent mice

Hemmerle, T.; Doll, F.; Neri, D., 2014:
Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis

Gutbrodt, K.L.; Schliemann, C.; Giovannoni, L.; Frey, K.; Pabst, T.; Klapper, W.; Berdel, W.E.; Neri, D., 2014:
Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia

Kim, H.L., 2014:
Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition

Randis, T.M.; Kulkarni, R.; Aguilar, J.L.; Ratner, A.J., 2009:
Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin

Park, K.; Tomlins, S.A.; Mudaliar, K.M.; Chiu, Y-Lin.; Esgueva, R.; Mehra, R.; Suleman, K.; Varambally, S.; Brenner, J.C.; MacDonald, T.; Srivastava, A.; Tewari, A.K.; Sathyanarayana, U.; Nagy, D.; Pestano, G.; Kunju, L.P.; Demichelis, F.; Chinnaiyan, A.M.; Rubin, M.A., 2010:
Antibody-based detection of ERG rearrangement-positive prostate cancer

Tomlins, S.A.; Palanisamy, N.; Siddiqui, J.; Chinnaiyan, A.M.; Kunju, L.P., 2012:
Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies

Khan, R.A.; Rashid, M.; Wang, D.; Zhang, Y.L., 2014:
Antibody-based detection of alkaline phosphatase in lepidopteran insects (Lepidoptera: Noctuidae)

Leal, Y.A.; Flores, L.L.; García-Cortés, L.B.; Cedillo-Rivera, R.; Torres, J., 2008:
Antibody-based detection tests for the diagnosis of Helicobacter pylori infection in children: a meta-analysis

Ramírez, H.; Román, B.San.; Glaria, I.; Reina, R.; Hernández, M.M.; de Andrés, X.; Crespo, H.; Hichou, B.; Cianca, S.; Goñi, C.; Grandas, A.; García-Pastor, L.; Vijil, L.E.; Quintín, F.; Grilló, M.J.; de Andrés, D.; Amorena, B., 2010:
Antibody-based diagnosis of small ruminant lentivirus infection in seminal fluid

Kim, H.Jin.; Lee, S.Jae.; Kim, H-Jin., 2008:
Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant

Loo, D.T.; Mather, J.P., 2008:
Antibody-based identification of cell surface antigens: targets for cancer therapy

Wang, R.E.; Zhang, Y.; Tian, L.; Cai, W.; Cai, J., 2014:
Antibody-based imaging of HER-2: moving into the clinic

Warram, J.M.; de Boer, E.; Sorace, A.G.; Chung, T.K.; Kim, H.; Pleijhuis, R.G.; van Dam, G.M.; Rosenthal, E.L., 2015:
Antibody-based imaging strategies for cancer

Premkumar, J.R.; Lev, O.; Marks, R.S.; Polyak, B.; Rosen, R.; Belkin, S., 2008:
Antibody-based immobilization of bioluminescent bacterial sensor cells

Heimbach, J.K.; Charlton, M.R., 2010:
Antibody-based immunosuppression following liver transplantation: the plot thickens

Sakaguchi, S.; Ishibashi, D.; Matsuda, H., 2009:
Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases

Gedeon, P.C.; Riccione, K.A.; Fecci, P.E.; Sampson, J.H., 2015:
Antibody-based immunotherapy for malignant glioma

Tse, B.W.C.; Collins, A.; Oehler, M.K.; Zippelius, A.; Heinzelmann-Schwarz, V.A., 2015:
Antibody-based immunotherapy for ovarian cancer: where are we at?

Johnson, E.; Dean, S.M.; Sondel, P.M., 2007:
Antibody-based immunotherapy in high-risk neuroblastoma

Weiner, L.M.; Murray, J.C.; Shuptrine, C.W., 2012:
Antibody-based immunotherapy of cancer

Kim, C-Beom.; Choi, Y.Yong.; Song, W.Keun.; Song, K-Bong., 2014:
Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor

Fiebig, H.; Kahlert, H.; Weber, B.; Suck, R.; Nandy, A.; Cromwell, O., 2010:
Antibody-based methods for standardization of allergoids and recombinant hypoallergens

Wingren, C.; Borrebaeck, C.A.K., 2009:
Antibody-based microarrays

Kassa, T.; Undesser, L.Pauli.; Hofstetter, H.; Hofstetter, O., 2011:
Antibody-based multiplex analysis of structurally closely related chiral molecules

Rauch, A.; Legendre, P.; Christophe, O.D.; Goudemand, J.; van Belle, E.; Vincentelli, Aé.; Denis, Cécile.V.; Susen, S.; Lenting, P.J., 2015:
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices

Häggmark, A.; Byström, S.; Ayoglu, B.; Qundos, U.; Uhlén, M.; Khademi, M.; Olsson, T.; Schwenk, J.M.; Nilsson, P., 2014:
Antibody-based profiling of cerebrospinal fluid within multiple sclerosis

Ellington, A.A.; Kullo, I.J.; Bailey, K.R.; Klee, G.G., 2010:
Antibody-based protein multiplex platforms: technical and operational challenges

Uhlén, M.; Oksvold, P.; Älgenäs, C.; Hamsten, C.; Fagerberg, L.; Klevebring, D.; Lundberg, E.; Odeberg, J.; Pontén, F.; Kondo, T.; Sivertsson, Åsa., 2012:
Antibody-based protein profiling of the human chromosome 21

Solier, C.; Langen, H., 2014:
Antibody-based proteomics and biomarker research - current status and limitations

Lindskog, C.; Asplund, A.; Engkvist, M.; Uhlen, M.; Korsgren, O.; Ponten, F., 2010:
Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets

Uemura, N.; Nakanishi, Y.; Kato, H.; Nagino, M.; Hirohashi, S.; Kondo, T., 2009:
Antibody-based proteomics for esophageal cancer: Identification of proteins in the nuclear factor-kappaB pathway and mitotic checkpoint

Voshol, H.; Ehrat, M.; Traenkle, J.; Bertrand, E.; van Oostrum, J., 2010:
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays

Ivey, R.G.; Subramanian, O.; Lorentzen, T.D.; Paulovich, A.G., 2009:
Antibody-based screen for ionizing radiation-dependent changes in the Mammalian proteome for use in biodosimetry

Byrne, B.; Stack, E.; Gilmartin, N.; O'Kennedy, R., 2009:
Antibody-based sensors: principles, problems and potential for detection of pathogens and associated toxins

Clancy, C.J.; Cheng, S.; Nguyen, M.Hong., 2009:
Antibody-based strategy to identify Candida albicans genes expressed during infections

Moreau, T.; Faye, Cément.; Baqué, M.; Desvignes, I.; Coussot, Gëlle.; Pascal, R.; Vandenabeele-Trambouze, O., 2012:
Antibody-based surfaces: rapid characterization using two complementary colorimetric assays

Qing, J.; Du, X.; Chen, Y.; Chan, P.; Li, H.; Wu, P.; Marsters, S.; Stawicki, S.; Tien, J.; Totpal, K.; Ross, S.; Stinson, S.; Dornan, D.; French, D.; Wang, Q-Rena.; Stephan, J-Philippe.; Wu, Y.; Wiesmann, C.; Ashkenazi, A., 2009:
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

Frey, K.; Zivanovic, A.; Schwager, K.; Neri, D., 2011:
Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation

Parry, P.V.; Engh, J.A., 2013:
Antibody-based therapeutic targeting of human neuroblastoma

Feng, Y.; Dimitrov, D.S., 2012:
Antibody-based therapeutics against components of the IGF system

Reichert, J.M., 2011:
Antibody-based therapeutics to watch in 2011

Le Jeune, C.; Thomas, X., 2015:
Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia

Oral, H.B.; Akdis, C.A., 2000 :
Antibody-based therapies in infectious diseases

Iikuni, N.; La Cava, A., 2009:
Antibody-based therapies in systemic lupus erythematosus

Pul, R.; Dodel, R.; Stangel, M., 2011:
Antibody-based therapy in Alzheimer's disease

Noguchi, T.; Ritter, G.; Nishikawa, H., 2013:
Antibody-based therapy in colorectal cancer

Cowan, A.J.; Laszlo, G.S.; Estey, E.H.; Walter, R.B., 2014:
Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin

Morris, J.C.; Waldmann, T.A., 2009:
Antibody-based therapy of leukaemia

Li, C.; Chacko, A-Marie.; Hu, J.; Hasegawa, K.; Swails, J.; Grasso, L.; El-Deiry, W.S.; Nicolaides, N.; Muzykantov, V.R.; Divgi, C.R.; Coukos, G., 2015:
Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model

Schliemann, C.; Neri, D., 2010:
Antibody-based vascular tumor targeting

Agrawal, A.K.; Gupta, C.M., 2000:
Antibody-bearing liposomes as chloroquine vehicles in treatment of murine malaria

Varich, N.L.; Sadykova, G.K.; Prilipov, A.G.; Kochergin-Nikitsky, K.S.; Kushch, A.A.; Masalova, O.V.; Klimova, R.R.; Gitelman, A.K.; Kaverin, N.V., 2011:
Antibody-binding epitope differences in the nucleoprotein of avian and mammalian influenza A viruses

Liu, X.; Liu, R.; Tang, Y.; Zhang, L.; Hou, X.; Lv, Y., 2012:
Antibody-biotemplated HgS nanoparticles: extremely sensitive labels for atomic fluorescence spectrometric immunoassay

Fujii, Y.; Anderson, J.M.; Matsuda, T., 2008:
Antibody-bound cell microarray for immunophenotyping: surface modification and lymphocyte subpopulations

Climent, E.; Martínez-Máñez, Rón.; Maquieira, A.; Sancenón, Félix.; Marcos, M.Dolores.; Brun, E.M.; Soto, J.; Amorós, P., 2012:
Antibody-capped mesoporous nanoscopic materials: design of a probe for the selective chromo-fluorogenic detection of finasteride

Ishikawa, F.; Uno, K.; Nishikawa, M.; Tsumuraya, T.; Fujii, I., 2014:
Antibody-catalyzed decarboxylation and aldol reactions using a primary amine molecule as a functionalized small nonprotein component

Saleh, M.; Soliman, H.; Haenen, O.; El-Matbouli, M., 2011:
Antibody-coated gold nanoparticles immunoassay for direct detection of Aeromonas salmonicida in fish tissues

Cimini, A.; D'Angelo, B.; Das, S.; Gentile, R.; Benedetti, E.; Singh, V.; Monaco, A.Maria.; Santucci, S.; Seal, S., 2012:
Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways

Jacobs, M.; Panneer Selvam, A.; Craven, J.Engel.; Prasad, S., 2015:
Antibody-conjugated gold nanoparticle-based immunosensor for ultra-sensitive detection of troponin-T

Day, E.S.; Bickford, L.R.; Slater, J.H.; Riggall, N.S.; Drezek, R.A.; West, J.L., 2011:
Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer

Cardoso, M.M.; Peça, I.N.; Roque, A.C.A., 2013:
Antibody-conjugated nanoparticles for therapeutic applications

Waseem, S.; Allen, M.A.; Schreier, S.; Udomsangpetch, R.; Bhakdi, S.C., 2015:
Antibody-conjugated paramagnetic nanobeads: kinetics of bead-cell binding

Skaat, H.; Corem-Slakmon, E.; Grinberg, I.; Last, D.; Goez, D.; Mardor, Y.; Margel, S., 2014:
Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils

Kontermann, R.E., 2012:
Antibody-cytokine fusion proteins

Müller, D., 2015:
Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments

Ortiz-Sánchez, E.; Helguera, G.; Daniels, T.R.; Penichet, M.L., 2008:
Antibody-cytokine fusion proteins: applications in cancer therapy

Singh, R.; Erickson, H.K., 2009:
Antibody-cytotoxic agent conjugates: preparation and characterization

Cabeza Meckert, P.M.; Chambo, J.G.; Spinelli, O.M.; Laguens, R.P., 1991:
Antibody-dependent Cytotoxicity of Human Platelets Against Trypanosoma Cruzi

Wang, S-Fan.; Tseng, S-Pin.; Yen, C-Hung.; Yang, J-Yuan.; Tsao, C-Han.; Shen, C-Wei.; Chen, K-Hsuan.; Liu, F-Tong.; Liu, W-Tse.; Chen, Y-Ming.Arthur.; Huang, J.C., 2014:
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

Couzi, L.; Pitard, V.; Sicard, X.; Garrigue, I.; Hawchar, O.; Merville, P.; Moreau, J-François.; Déchanet-Merville, J., 2012:
Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)

Hubert, P.; Amigorena, S., 2012:
Antibody-dependent cell cytotoxicity in monoclonal antibody-mediated tumor immunotherapy

Bruckheimer, E.M.; Fazenbaker, C.A.; Gallagher, S.; Mulgrew, K.; Fuhrmann, S.; Coffman, K.T.; Walsh, W.; Ready, S.; Cook, K.; Damschroder, M.; Kinch, M.; Kiener, P.A.; Woods, R.; Gao, C.; Dall'Acqua, W.; Wu, H.; Coats, S., 2009:
Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors

Hamada-Tsutsumi, S.; Suzuki, K.; Akahori, Y., 2011:
Antibody-dependent cell-mediated cytotoxicity is induced by a single-chain Fv-protein III fusion in the presence of a rabbit anti-protein III polyclonal antibody

Chan, W.Keung.; Kung Sutherland, M.; Li, Y.; Zalevsky, J.; Schell, S.; Leung, W., 2013:
Antibody-dependent cell-mediated cytotoxicity overcomes NK cell resistance in MLL-rearranged leukemia expressing inhibitory KIR ligands but not activating ligands

Xie, X.; McLean, M.D.; Hall, J.Christopher., 2010:
Antibody-dependent cell-mediated cytotoxicity- and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad

Asmal, M.; Sun, Y.; Lane, S.; Yeh, W.; Schmidt, S.D.; Mascola, J.R.; Letvin, N.L., 2011:
Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses

Forthal, D.N.; Landucci, G.; Chohan, B.; Richardson, B.A.; McClelland, R.Scott.; Jaoko, W.; Blish, C.; Overbaugh, J., 2013:
Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection

Kobayashi, E.; Motoi, S.; Sugiura, M.; Kajikawa, M.; Kojima, S.; Kohroki, J.; Masuho, Y., 2015:
Antibody-dependent cellular cytotoxicity and cytokine/chemokine secretion by KHYG-1 cells stably expressing FcγRIIIA

Koch, T.; Derer, S.; Staudinger, M.; Rossen, K.; Glorius, P.; Peipp, M.; Kellner, C.; Kunzendorf, U.; Valerius, T.; Dechant, M., 2014:
Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysis

Shimodaira, H.; Komine, K.; Soeda, H.; Ishioka, C., 2010:
Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody

Madhavi, V.; Ana-Sosa-Batiz, F.E.; Jegaskanda, S.; Center, R.J.; Winnall, W.R.; Parsons, M.S.; Ananworanich, J.; Cooper, D.A.; Kelleher, A.D.; Hsu, D.; Pett, S.; Stratov, I.; Kramski, M.; Kent, S.J., 2015:
Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy

Gorlani, A.; Forthal, D.N., 2014:
Antibody-dependent enhancement and the risk of HIV infection

Tsai, T-Ting.; Chuang, Y-Jui.; Lin, Y-Shin.; Chang, C-Peng.; Wan, S-Wen.; Lin, S-Hsiang.; Chen, C-Ling.; Lin, C-Feng., 2016:
Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes

Takano, T.; Kawakami, C.; Yamada, S.; Satoh, R.; Hohdatsu, T., 2009:
Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection

Nakayama, E.; Tomabechi, D.; Matsuno, K.; Kishida, N.; Yoshida, R.; Feldmann, H.; Takada, A., 2011:
Antibody-dependent enhancement of Marburg virus infection

Bao, D.; Wang, R.; Qiao, S.; Wan, B.; Wang, Y.; Liu, M.; Shi, X.; Guo, J.; Zhang, G., 2014:
Antibody-dependent enhancement of PRRSV infection down-modulates TNF-α and IFN-β transcription in macrophages

Jarasch-Althof, N.; Wiesener, N.; Schmidtke, M.; Wutzler, P.; Henke, A., 2011:
Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes

Ito, M.; Mukai, R-zabro.; Takasaki, T.; Kotaki, A.; Kurane, I., 2010:
Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus

Ayala-Nuñez, N.V.; Jarupathirun, P.; Kaptein, S.J.F.; Neyts, J.; Smit, J.M., 2014:
Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative

Yip, M.Shum.; Leung, N.Hiu.Lan.; Cheung, C.Yan.; Li, P.Hung.; Lee, H.Hok.Yeung.; Daëron, M.; Peiris, J.Sriyal.Malik.; Bruzzone, R.; Jaume, M., 2015:
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus

Longmire, R.L.; Ryan, S.; McMillan, R.; Lightsey, A.; Heath, V., 1978:
Antibody-dependent lymphocytotoxicity induced by immunoglobulin G from Hodgkin's disease splenic lymphocytes

Triulzi, C.; Vertuani, S.; Curcio, C.; Antognoli, A.; Seibt, J.; Akusjärvi, Göran.; Wei, W-Zen.; Cavallo, F.; Kiessling, R., 2010:
Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors

May, K.; Grube, M.; Malhotra, I.; Long, C.A.; Singh, S.; Mandaliya, K.; Siegmund, W.; Fusch, C.; Schneider, H.; King, C.L., 2010:
Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model

Dong, X-Ya.; Wang, W-Qian.; Zhao, Y.; Li, X-Dong.; Fang, Z-Gang.; Lin, D-Jun.; Xiao, R-Zhi.; Huang, R-Wei.; Pan, G-Jin.; Liu, J-Jun., 2014:
Antibody-directed double suicide gene therapy targeting of MUC1- positive leukemia cells in vitro and in vivo

Tietze, L.F.; Krewer, B., 2009:
Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies

Wu, D-tze.; Seita, Y.; Zhang, X.; Lu, C-Wei.; Roth, M.J., 2012:
Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells

Zhang, X.; Roth, M.J., 2011:
Antibody-directed lentiviral gene transduction in early immature hematopoietic progenitor cells

Murphy, K.T.; Ryall, J.G.; Snell, S.M.; Nair, L.; Koopman, Ré.; Krasney, P.A.; Ibebunjo, C.; Holden, K.S.; Loria, P.M.; Salatto, C.T.; Lynch, G.S., 2010:
Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice

Murphy, K.T.; Koopman, Ré.; Naim, T.; Léger, B.; Trieu, J.; Ibebunjo, C.; Lynch, G.S., 2010:
Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function

Satishkumar, R.; Vertegel, A.A., 2012:
Antibody-directed targeting of lysostaphin adsorbed onto polylactide nanoparticles increases its antimicrobial activity against S. aureus in vitro

Grundy, A., 2014:
Antibody-discovery company announces partnership with two pharmaceutical corporations

Sassoon, I.; Blanc, Véronique., 2014:
Antibody-drug conjugate (ADC) clinical pipeline: a review

Wright, L.; Baughman, S.; Wake, A., 2014:
Antibody-drug conjugate drug development: where are the challenges?

Anonymous, 2014:
Antibody-drug conjugate may inhibit pancreatic cancer

Wagner-Rousset, E.; Janin-Bussat, M-Claire.; Colas, O.; Excoffier, M.; Ayoub, D.; Haeuw, J-François.; Rilatt, I.; Perez, M.; Corvaïa, N.; Beck, A., 2014:
Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion

Anderl, J.; Faulstich, H.; Hechler, T.; Kulke, M., 2014:
Antibody-drug conjugate payloads

Bander, N.H., 2014:
Antibody-drug conjugate target selection: critical factors

Teicher, B.A., 2010:
Antibody-drug conjugate targets

Bander, N.H.; Czuczman, M.S.; Younes, A., 2013:
Antibody-drug conjugate technology development for hematologic disorders

Bertholjotti, I., 2011:
Antibody-drug conjugate--a new age for personalized cancer treatment

Ornes, S., 2013:
Antibody-drug conjugates

Adair, J.R.; Howard, P.W.; Hartley, J.A.; Williams, D.G.; Chester, K.A., 2013:
Antibody-drug conjugates - a perfect synergy

Lin, L.; Ding, Q.; Tang, Q.; Zhang, Z-zhen.; Dai, Z.; Zhan, J-biao., 2013:
Antibody-drug conjugates and their application in the treatment of hematological malignancies

Sun, Y.; Yu, F.; Sun, B-Wang., 2012:
Antibody-drug conjugates as targeted cancer therapeutics

Chu, Y-Waye.; Polson, A., 2013:
Antibody-drug conjugates for the treatment of B-cell non-Hodgkin's lymphoma and leukemia

Polson, A.G.; Calemine-Fenaux, J.; Chan, P.; Chang, W.; Christensen, E.; Clark, S.; de Sauvage, F.J.; Eaton, D.; Elkins, K.; Elliott, J.Michael.; Frantz, G.; Fuji, R.N.; Gray, A.; Harden, K.; Ingle, G.S.; Kljavin, N.M.; Koeppen, H.; Nelson, C.; Prabhu, S.; Raab, H.; Ross, S.; Slaga, D.S.; Stephan, J-Philippe.; Scales, S.J.; Spencer, S.D.; Vandlen, R.; Wranik, B.; Yu, S-Fan.; Zheng, B.; Ebens, A., 2009:
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection

Sievers, E.L.; Senter, P.D., 2013:
Antibody-drug conjugates in cancer therapy

Leslie, L.A.; Younes, A., 2015:
Antibody-drug conjugates in hematologic malignancies

Gonçalves, A.; Trédan, O.; Villanueva, C.; Dumontet, C., 2013:
Antibody-drug conjugates in oncology: from the concept to trastuzumab emtansine (T-DM1)

Sammet, B.; Steinkühler, C.; Sewald, N., 2014:
Antibody-drug conjugates in tumor therapy

Ricart, A.D., 2012:
Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin

Olson, W.C.; Israel, R.J., 2014:
Antibody-drug conjugates targeting prostate-specific membrane antigen

Chofflon, I.; Dietrich, P-Yves.; Thang, N-Nam.Tran., 2013:
Antibody-drug conjugates: a new therapeutic class?

Chari, R.V.J.; Miller, M.L.; Widdison, W.C., 2015:
Antibody-drug conjugates: an emerging concept in cancer therapy

Leal, M.; Sapra, P.; Hurvitz, S.A.; Senter, P.; Wahl, A.; Schutten, M.; Shah, D.K.; Haddish-Berhane, N.; Kabbarah, O., 2014:
Antibody-drug conjugates: an emerging modality for the treatment of cancer

Perez, H.L.; Cardarelli, P.M.; Deshpande, S.; Gangwar, S.; Schroeder, G.M.; Vite, G.D.; Borzilleri, R.M., 2015:
Antibody-drug conjugates: current status and future directions

Ducry, L.; Stump, B., 2010:
Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies

Beck, A.; Reichert, J.M., 2014:
Antibody-drug conjugates: present and future

Alley, S.C.; Okeley, N.M.; Senter, P.D., 2010:
Antibody-drug conjugates: targeted drug delivery for cancer

Falvo, E.; Tremante, E.; Fraioli, R.; Leonetti, C.; Zamparelli, C.; Boffi, A.; Morea, V.; Ceci, P.; Giacomini, P., 2014:
Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin

Drachman, J.G.; Senter, P.D., 2014:
Antibody-drug conjugates: the chemistry behind empowering antibodies to fight cancer

Goldmacher, V.S.; Kovtun, Y.V., 2012:
Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells

Conde, Jão.; Bao, C.; Cui, D.; Baptista, P.V.; Tian, F., 2014:
Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics

Cova, E.; Colombo, M.; Inghilleri, S.; Morosini, M.; Miserere, S.; Peñaranda-Avila, J.; Santini, B.; Piloni, D.; Magni, S.; Gramatica, F.; Prosperi, D.; Meloni, F., 2015:
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction

Harbers, S.O.; Crocker, A.; Catalano, G.; D'Agati, V.; Jung, S.; Desai, D.D.; Clynes, R., 2007:
Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance

He, X.; Sun, X.; Wang, J.; Wang, X.; Zhang, Q.; Tzipori, S.; Feng, H., 2009:
Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A

Wisdom, G.B., 1988:
Antibody-enzyme conjugate formation

Andrady, C.; Sharma, S.K.; Chester, K.A., 2011:
Antibody-enzyme fusion proteins for cancer therapy

Wilffert, D.; Reis, C.R.; Hermans, J.; Govorukhina, N.; Tomar, T.; de Jong, S.; Quax, W.J.; van de Merbel, N.C.; Bischoff, R., 2014:
Antibody-free LC-MS/MS quantification of rhTRAIL in human and mouse serum

Shi, T.; Qian, W-Jun., 2013:
Antibody-free PRISM-SRM for multiplexed protein quantification: is this the new competition for immunoassays in bioanalysis?

Rossetti, C.; Abdel Qader, A.; Halvorsen, T.Grønhaug.; Sellergren, Börje.; Reubsaet, Léon., 2015:
Antibody-free biomarker determination: exploring molecularly imprinted polymers for pro-gastrin releasing peptide

Wu, H-Jen.; Li, Y.; Fan, J.; Deng, Z.; Hu, Z.; Liu, X.; Graviss, E.A.; Ferrari, M.; Ma, X.; Hu, Y., 2014:
Antibody-free detection of Mycobacterium tuberculosis antigen using customized nanotraps

Ding, X.; Yang, K-Lin., 2014:
Antibody-free detection of human chorionic gonadotropin by use of liquid crystals

Alpha-Bazin, Béatrice.; Quéméneur, E., 2013:
Antibody-free detection of phosphoserine/threonine containing peptides by homogeneous time-resolved fluorescence

Wisastra, R.; Poelstra, K.; Bischoff, R.; Maarsingh, H.; Haisma, H.J.; Dekker, F.J., 2012:
Antibody-free detection of protein tyrosine nitration in tissue sections

Matheson, N.J.; Peden, A.A.; Lehner, P.J., 2015:
Antibody-free magnetic cell sorting of genetically modified primary human CD4+ T cells by one-step streptavidin affinity purification

Kim, M.; Park, Y-Sun.; Shin, D-Sik.; Kim, J.; Kim, B-Gee.; Lee, Y-Sik., 2011:
Antibody-free peptide substrate screening of serine/threonine kinase (protein kinase A) with a biotinylated detection probe

Minaker, S.A.; Daze, K.D.; Ma, M.C.F.; Hof, F., 2012:
Antibody-free reading of the histone code using a simple chemical sensor array

Shi, T.; Fillmore, T.L.; Sun, X.; Zhao, R.; Schepmoes, A.A.; Hossain, M.; Xie, F.; Wu, S.; Kim, J-Seo.; Jones, N.; Moore, R.J.; Pasa-Tolić, L.; Kagan, J.; Rodland, K.D.; Liu, T.; Tang, K.; Camp, D.G.; Smith, R.D.; Qian, W-Jun., 2012:
Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum

Guarrotxena, N.; Bazan, G.C., 2011:
Antibody-functionalized SERS tags with improved sensitivity

Mittal, S.; Wong, I.Y.; Deen, W.M.; Toner, M., 2012:
Antibody-functionalized fluid-permeable surfaces for rolling cell capture at high flow rates

Buyukserin, F.; Medley, C.D.; Mota, M.O.; Kececi, K.; Rogers, R.R.; Tan, W.; Martin, C.R., 2008:
Antibody-functionalized nano test tubes target breast cancer cells

Karmani, L.; Labar, D.; Valembois, V.; Bouchat, V.; Nagaswaran, P.Ganesh.; Bol, A.; Gillart, J.; Levêque, P.; Bouzin, C.; Bonifazi, D.; Michiels, C.; Feron, O.; Grégoire, V.; Lucas, Séphane.; Vander Borght, T.; Gallez, B., 2014:
Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice

Wen, Y.; Liu, W.; Bagia, C.; Zhang, S.; Bai, M.; Janjic, J.M.; Giannoukakis, N.; Gawalt, E.S.; Meng, W.S., 2015:
Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells

Triulzi, R.C.; Micic, M.; Orbulescu, J.; Giordani, S.; Mueller, B.; Leblanc, R.M., 2008:
Antibody-gold quantum dot-PAMAM dendrimer complex as an immunoglobulin immunoassay

Anonymous, 2010:
Antibody-guided drug shows encouraging activity in metastatic breast cancer

Sack, J.T.; Stephanopoulos, N.; Austin, D.C.; Francis, M.B.; Trimmer, J.S., 2014:
Antibody-guided photoablation of voltage-gated potassium currents

Mahara, A.; Yamaoka, T., 2010:
Antibody-immobilized column for quick cell separation based on cell rolling

Yin, D.; Ulbricht, M., 2014:
Antibody-imprinted membrane adsorber via two-step surface grafting

Ireland, S.J.; Blazek, M.; Harp, C.T.; Greenberg, B.; Frohman, E.M.; Davis, L.S.; Monson, N.L., 2012:
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity

Shim, S.; Stemke-Hale, K.; Tsimberidou, A.M.; Noshari, J.; Anderson, T.E.; Gascoyne, P.R.C., 2014:
Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis

He, J.; Sun, X.; Shi, T.; Schepmoes, A.A.; Fillmore, T.L.; Petyuk, V.A.; Xie, F.; Zhao, R.; Gritsenko, M.A.; Yang, F.; Kitabayashi, N.; Chae, S-Suk.; Rubin, M.A.; Siddiqui, J.; Wei, J.T.; Chinnaiyan, A.M.; Qian, W-Jun.; Smith, R.D.; Kagan, J.; Srivastava, S.; Rodland, K.D.; Liu, T.; Camp, D.G., 2015:
Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer

Kamerbeek, C.B.; Borroni, V.; Pediconi, Mía.F.; Sato, S.B.; Kobayashi, T.; Barrantes, F.J., 2014:
Antibody-induced acetylcholine receptor clusters inhabit liquid-ordered and liquid-disordered domains

Andersen, L.M.; Andreasen, P.A.; Svendsen, I.; Keemink, J.; Østergaard, H.; Persson, E., 2012:
Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways

Dressler, D.; Wohlfahrt, K.; Meyer-Rogge, E.; Wiest, L.; Bigalke, H., 2011:
Antibody-induced failure of botulinum toxin a therapy in cosmetic indications

Modjtahedi, H.; Dean, C., 1995:
Antibody-induced inhibition of growth of egfr overexpressing tumors occurs in the absence of receptor down-regulation

Geddie, M.L.; Matsumura, I., 2007:
Antibody-induced oligomerization and activation of an engineered reporter enzyme

Michaelsen, T.E.; Aase, A., 2001:
Antibody-induced opsonophagocytosis of serogroup B meningococci measured by flow cytometry

Stengel, G.; Bee, E.Kristina., 2012:
Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines

Cummings, R.J.; Mitra, S.; Lord, E.M.; Foster, T.H., 2008:
Antibody-labeled fluorescence imaging of dendritic cell populations in vivo

Danila, D.; Partha, R.; Elrod, D.B.; Lackey, M.; Casscells, S.Ward.; Conyers, J.L., 2010:
Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography

Haab, B.B., 2010:
Antibody-lectin sandwich arrays for biomarker and glycobiology studies

Zhang, K.; Hao, L.; Hurst, S.J.; Mirkin, C.A., 2013:
Antibody-linked spherical nucleic acids for cellular targeting

Kovtun, Y.V.; Audette, C.A.; Mayo, M.F.; Jones, G.E.; Doherty, H.; Maloney, E.K.; Erickson, H.K.; Sun, X.; Wilhelm, S.; Ab, O.; Lai, K.C.; Widdison, W.C.; Kellogg, B.; Johnson, H.; Pinkas, J.; Lutz, R.J.; Singh, R.; Goldmacher, V.S.; Chari, R.V.J., 2010:
Antibody-maytansinoid conjugates designed to bypass multidrug resistance

Lutz, R.J.; Whiteman, K.R., 2010:
Antibody-maytansinoid conjugates for the treatment of myeloma

Bux, J., 2011:
Antibody-mediated (immune) transfusion-related acute lung injury

James, S.E.; Orgun, N.N.; Tedder, T.F.; Shlomchik, M.J.; Jensen, M.C.; Lin, Y.; Greenberg, P.D.; Press, O.W., 2010:
Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice

Heinze, E.; Baldwin, S.; Chan, G.; Hansen, J.; Song, J.; Clements, D.; Aragon, R.; Nishimura, R.; Reeves, M.; Weisbart, R., 2009:
Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo

Onzuka, T.; Tomita, Y.; Okano, S.; Shimizu, I.; Yamada, H.; Yoshikai, Y.; Tominaga, R., 2010:
Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice

Wu, A-Luen.; Feng, B.; Chen, M.Z.; Kolumam, G.; Zavala-Solorio, J.; Wyatt, S.K.; Gandham, V.D.; Carano, R.A.D.; Sonoda, J., 2013:
Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia

Lefaucheur, C.; Nochy, D.; Glotz, D., 2008:
Antibody-mediated acute rejection

Papadimitriou, J.C.; Drachenberg, C.B.; Ramos, E.; Kukuruga, D.; Klassen, D.K.; Ugarte, R.; Nogueira, J.; Cangro, C.; Weir, M.R.; Haririan, A., 2013:
Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies

Arévalo-Herrera, M.; Soto, L.; Perlaza, B.Liliana.; Céspedes, N.; Vera, O.; Lenis, A.Milena.; Bonelo, A.; Corradin, G.; Herrera, Sócrates., 2011:
Antibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein

Reiche, S.; Bussmann, B.M.; Dwai, Y.; Jassoy, C., 2010:
Antibody-mediated binding of fluorescent HIV Gag and influenza nucleoprotein tetramers to blood cells

Yokoyama, S.; Watanabe, N.; Sato, N.; Perera, P-Yu.; Filkoski, L.; Tanaka, T.; Miyasaka, M.; Waldmann, T.A.; Hiroi, T.; Perera, L.P., 2009:
Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes

Van Aarsen, L.A.Koopman.; Leone, D.R.; Ho, S.; Dolinski, B.M.; McCoon, P.E.; LePage, D.J.; Kelly, R.; Heaney, G.; Rayhorn, P.; Reid, C.; Simon, K.J.; Horan, G.S.; Tao, N.; Gardner, H.A.; Skelly, M.M.; Gown, A.M.; Thomas, G.J.; Weinreb, P.H.; Fawell, S.E.; Violette, S.M., 2008:
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism

Shapiro, E.M.; Medford-Davis, L.N.; Fahmy, T.M.; Dunbar, C.E.; Koretsky, A.P., 2007:
Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI

Pálóczi, K., 2007:
Antibody-mediated cell-specific hematopoietic autoimmune disorders

Horton, H.M.; Chu, S.Y.; Ortiz, E.C.; Pong, E.; Cemerski, S.; Leung, I.W.L.; Jacob, N.; Zalevsky, J.; Desjarlais, J.R.; Stohl, W.; Szymkowski, D.E., 2011:
Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus

La Greca, F.; Haynes, C.; Stijlemans, B.; De Trez, C.; Magez, S., 2014:
Antibody-mediated control of Trypanosoma vivax infection fails in the absence of tumour necrosis factor

Hemmerle, T.; Zgraggen, S.; Matasci, M.; Halin, C.; Detmar, M.; Neri, D., 2015:
Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation

Mårlind, J.; Kaspar, M.; Trachsel, E.; Sommavilla, R.; Hindle, S.; Bacci, C.; Giovannoni, L.; Neri, D., 2008:
Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy

Kim, S-Soo.; Subramanya, S.; Peer, D.; Shimaoka, M.; Shankar, P., 2011:
Antibody-mediated delivery of siRNAs for anti-HIV therapy

Poirier, N.; Haudebourg, T.; Brignone, C.; Dilek, N.; Hervouet, J.; Minault, D.; Coulon, F.; de Silly, R.V.; Triebel, F.; Blancho, G.; Vanhove, B., 2011:
Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates

Duff, C.J.; Scott, M.J.; Kirby, I.T.; Hutchinson, S.E.; Martin, S.L.; Hooper, N.M., 2009:
Antibody-mediated disruption of the interaction between PCSK9 and the low-density lipoprotein receptor

Pollak, T.A.; Lennox, B.R.; Vincent, A.; Nicholson, T.R., 2012:
Antibody-mediated encephalitis and psychosis

Lennox, B.R.; Coles, A.J.; Vincent, A., 2012:
Antibody-mediated encephalitis: a treatable cause of schizophrenia

Yoong, P.; Pier, G.B., 2010:
Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection

von Kietzell, K.; Pozzuto, T.; Heilbronn, R.; Grössl, T.; Fechner, H.; Weger, S., 2014:
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q

Itoh, H.; Inoue, M., 2014:
Antibody-mediated functional control of a dansylated polytheonamide mimic

Valenzuela, N.M.; McNamara, J.T.; Reed, E.F., 2014:
Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms

Baldwin, W.M.; Sanfilippo, F., 1987:
Antibody-mediated graft versus host reactions in renal transplantation

Dent, A.E.; Bergmann-Leitner, E.S.; Wilson, D.W.; Tisch, D.J.; Kimmel, R.; Vulule, J.; Sumba, P.Odada.; Beeson, J.G.; Angov, E.; Moormann, A.M.; Kazura, J.W., 2008:
Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults

Robertson, E.J.; Casadevall, A., 2009:
Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation

Wilks, J.; Beilinson, H.; Theriault, B.; Chervonsky, A.; Golovkina, T., 2014:
Antibody-mediated immune control of a retrovirus does not require the microbiota

Yu, H.; Stowell, S.R.; Bernardo, L.; Hendrickson, J.E.; Zimring, J.C.; Amash, A.; Uchikawa, M.; Lazarus, A.H., 2014:
Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model

Fantappiè, L.; de Santis, M.; Chiarot, E.; Carboni, F.; Bensi, G.; Jousson, O.; Margarit, I.; Grandi, G., 2014:
Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen

Shannon, J.G.; Cockrell, D.C.; Takahashi, K.; Stahl, G.L.; Heinzen, R.A., 2009:
Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent

Solomon, B., 2007:
Antibody-mediated immunotherapy for Alzheimer's disease

Wang, Z.; Low, P.A.; Vernino, S., 2010:
Antibody-mediated impairment and homeostatic plasticity of autonomic ganglionic synaptic transmission

Hegerle, N.; Guiso, N., 2014:
Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population

Williams, S.K.; Maier, O.; Fischer, R.; Fairless, R.; Hochmeister, S.; Stojic, A.; Pick, L.; Haar, D.; Musiol, S.; Storch, M.K.; Pfizenmaier, K.; Diem, R., 2014:
Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis

Burden, R.E.; Gormley, J.A.; Jaquin, T.J.; Small, D.M.; Quinn, D.J.; Hegarty, S.M.; Ward, C.; Walker, B.; Johnston, J.A.; Olwill, S.A.; Scott, C.J., 2009:
Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis

Pai, R.; French, D.; Ma, N.; Hotzel, K.; Plise, E.; Salphati, L.; Setchell, K.D.R.; Ware, J.; Lauriault, V.; Schutt, L.; Hartley, D.; Dambach, D., 2012:
Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys

Chang, J.; Yang, L.; Kouadir, M.; Peng, Y.; Zhang, S.; Shi, F.; Zhou, X.; Yin, X.; Zhao, D., 2013:
Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia

Yermakova, A.; Klokk, T.Irene.; Cole, R.; Sandvig, K.; Mantis, N.J., 2014:
Antibody-mediated inhibition of ricin toxin retrograde transport

Loupy, A.; Hill, G.S.; Nochy, D.; Legendre, C., 2010:
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

Nimmerjahn, F.; Ravetch, J.V., 2010:
Antibody-mediated modulation of immune responses

Sato, S.; Johnson, W., 2007:
Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS

Shedlock, D.J.; Bailey, M.A.; Popernack, P.M.; Cunningham, J.M.; Burton, D.R.; Sullivan, N.J., 2010:
Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms

Dowd, K.A.; Pierson, T.C., 2011:
Antibody-mediated neutralization of flaviviruses: a reductionist view

Chehadeh, W.; Halim, M.A.; Al-Nakib, W., 2009:
Antibody-mediated opsonization of red blood cells in parvovirus B19 infection

Freire, M.O.; You, H-Keun.; Kook, J-Ki.; Choi, J-Ho.; Zadeh, H.H., 2012:
Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies

Freire, M.O.; Kim, H.Kyun.; Kook, J-Ki.; Nguyen, A.; Zadeh, H.H., 2013:
Antibody-mediated osseous regeneration: the early events in the healing response

Lu, Y.; Wang, W.; Mao, H.; Hu, H.; Wu, Y.; Chen, B-Guan.; Liu, Z., 2011:
Antibody-mediated platelet phagocytosis by human macrophages is inhibited by siRNA specific for sequences in the SH2 tyrosine kinase, Syk

Hu, Z-Quan.; Li, H-Ping.; Zhang, J-Bo.; Glinka, E.; Liao, Y-Cai., 2009:
Antibody-mediated prevention of Fusarium mycotoxins in the field

Gorrell, R.J.; Robins-Browne, R.M., 2009:
Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity

Barnett, S.W.; Burke, B.; Sun, Y.; Kan, E.; Legg, H.; Lian, Y.; Bost, K.; Zhou, F.; Goodsell, A.; Zur Megede, J.; Polo, J.; Donnelly, J.; Ulmer, J.; Otten, G.R.; Miller, C.J.; Vajdy, M.; Srivastava, I.K., 2010:
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant

Mestecky, J.; Raska, M.; Novak, J.; Alexander, R.C.; Moldoveanu, Z., 2010:
Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design

Suchkov, S.V.; Vvedenskaia, O.Iu.; Vostrikova, I.L.; Gabibov, A.G.; Kimova, M.V.; Burdakova, I.A.; Ponomarenko, N.A.; Pal'tsev, M.A., 2007:
Antibody-mediated proteolysis of myelin-associated proteins as a new mechanism of control over demyelinization processes in multiple sclerosis

Bossi, S.; Ferranti, B.; Martinelli, C.; Capasso, P.; de Marco, A., 2010:
Antibody-mediated purification of co-expressed antigen-antibody complexes

Akalin, E.; Watschinger, B., 2007:
Antibody-mediated rejection

Kittleson, M.M.; Kobashigawa, J.A., 2013:
Antibody-mediated rejection

Rangel, E.B.; Malheiros, D.M.A.C.; de Castro, M.Cristina.Ribeiro.; Antunes, I.; Torres, M.A.; Crescentini, Fábio.; Genzini, Tércio.; Perosa, M., 2010:
Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation

Hori, T.; Egawa, H.; Uemoto, S., 2012:
Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination

Willicombe, M.; Roufosse, C.; Brookes, P.; Galliford, J.W.; McLean, A.G.; Dorling, A.; Warrens, A.N.; Cook, T.H.; Cairns, T.D.; Taube, D., 2011:
Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome

Dick, Aé.A.S.; Horslen, S., 2013:
Antibody-mediated rejection after intestinal transplantation

Hsu, C-Y.; Chi, N-H.; Chou, N-K.; Shun, C-T.; Chen, Y-S.; Huang, S-C.; Yu, H-Y.; Wang, S-S., 2015:
Antibody-mediated rejection after orthotopic heart transplantation: a 9-year single-institution experience

Gulleroglu, K.; Baskin, E.; Bayrakci, U.Selda.; Turan, M.; Ozdemir, B.Handan.; Moray, G.; Karakayali, H.; Haberal, M., 2014:
Antibody-mediated rejection and treatment in pediatric patients: one center's experience

O'Leary, J.G.; Kaneku, H.; Demetris, A.J.; Marr, J.D.; Shiller, S.Michelle.; Susskind, B.M.; Tillery, G.W.; Terasaki, P.I.; Klintmalm, Göran.B., 2014:
Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss

Bentall, A.; Tyan, D.B.; Sequeira, F.; Everly, M.J.; Gandhi, M.J.; Cornell, L.D.; Li, H.; Henderson, N.A.; Raghavaiah, S.; Winters, J.L.; Dean, P.G.; Stegall, M.D., 2015:
Antibody-mediated rejection despite inhibition of terminal complement

Sureshkumar, K.K.; Hussain, S.M.; Carpenter, B.J.; Sandroni, S.E.; Marcus, R.J., 2007:
Antibody-mediated rejection following renal transplantation

Grafft, C.A.; Cornell, L.D.; Gloor, J.M.; Cosio, F.G.; Gandhi, M.J.; Dean, P.G.; Stegall, M.D.; Amer, H., 2010:
Antibody-mediated rejection following transplantation from an HLA-identical sibling

Kheradmand, T.; Anthony, T.L.; Harland, R.C.; Testa, G.; Hart, J.; Renz, J.; Te, H.S.; Marino, S.R., 2014:
Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature

Weissenbacher, A.; Hautz, T.; Zelger, B.; Zelger, B.G.; Mayr, V.; Brandacher, G.; Pratschke, J.; Schneeberger, S., 2014:
Antibody-mediated rejection in hand transplantation

Ticehurst, E.H.; Molina, M.R.; Frank, R.; Kearns, J.; Lal, P.; Goldberg, L.R.; Tsai, D.; Wald, J.; Kamoun, M., 2012:
Antibody-mediated rejection in heart transplant patients: long-term follow up of patients with high levels of donor-directed anti-DQ antibodies

Bierl, C.; Miller, B.; Prak, E.Luning.; Gasiewski, A.; Kearns, J.; Tsai, D.; Jessup, M.; Kamoun, M., 2008:
Antibody-mediated rejection in heart transplant recipients: potential efficacy of B-cell depletion and antibody removal

Pajaro, O.E.; Jaroszewski, D.E.; Scott, R.L.; Kalya, A.V.; Tazelaar, H.D.; Arabia, F.A., 2011:
Antibody-mediated rejection in heart transplantation: case presentation with a review of current international guidelines

Kim, M.; Martin, S.T.; Townsend, K.R.; Gabardi, S., 2015:
Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options

Lucas, J.G.; Co, J.P.; Nwaogwugwu, U.T.; Dosani, I.; Sureshkumar, K.K., 2011:
Antibody-mediated rejection in kidney transplantation: an update

Taner, T.; Stegall, M.D.; Heimbach, J.K., 2014:
Antibody-mediated rejection in liver transplantation: current controversies and future directions

Girnita, A.L.; McCurry, K.R.; Yousem, S.A.; Pilewski, J.; Zeevi, A., 2008:
Antibody-mediated rejection in lung transplantation: case reports

Westall, G.P.; Snell, G.I., 2015:
Antibody-mediated rejection in lung transplantation: fable, spin, or fact?

Glanville, A.R., 2010:
Antibody-mediated rejection in lung transplantation: myth or reality?

Glanville, A.R., 2013:
Antibody-mediated rejection in lung transplantation: turning myth into reality

Markiewicz-Kijewska, Młgorzata.; Kaliciński, P.; Kluge, Pław.; Piątosa, B.; Rękawek, A.; Jankowska, I.; Kostecka, E.; Kurowski, Pław.Norbert., 2014:
Antibody-mediated rejection in pediatric liver transplant recipients

Racusen, L.C.; Haas, M., 2007:
Antibody-mediated rejection in renal allografts: lessons from pathology

Biancone, L., 2008:
Antibody-mediated rejection in renal transplant: where are we now?

Hübscher, S.G., 2013:
Antibody-mediated rejection in the liver allograft

Splith, K.; Fellmer, P.; Matia, I.; Varga, M.; Oliverius, M.; Kuhn, S.; Feldbrügge, L.; Krenzien, F.; Hau, H-Michael.; Wiltberger, G.; Schmelzle, M.; Jonas, S., 2015:
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats

Barth, R.N.; Campos, L.; Kukuruga, D.L.; Drachenberg, C.; Philosophe, B., 2011:
Antibody-mediated rejection of renal allograft in combined liver-kidney transplant

Berry, G.J., 2013:
Antibody-mediated rejection of the cardiac allograft: where do we stand in 2012?

Lindley, K.J.; Ravichandran, A.K.; Schilling, J.; Joseph, S.M., 2012:
Antibody-mediated rejection of the heart in the setting of autoimmune demyelinating polyneuropathy: a case report and review of the literature

Torrealba, J.R.; Odorico, J., 2009:
Antibody-mediated rejection of the pancreas allograft

Swarnalatha, G.; Ram, R.; Santosh Pai, B.H.; Ramesh, V.; Dakshinamurty, K.Venkata., 2012:
Antibody-mediated rejection presenting as allograft hydronephrosis

Sis, B.; Grynoch, R.; Murray, A.G.; Campbell, P.; Solez, K., 2007:
Antibody-mediated rejection with a striking interstitial monocyte/macrophage infiltration in a renal allograft under FTY720 treatment

Angelini, A.; Castellani, C.; Poli, F.; Benazzi, E.; Torregrossa, G.; Tona, F.; Gambino, A.; Caforio, A.P.; Feltrin, G.; Toscano, G.; Valente, M.; Thiene, G.; Gerosa, G., 2008:
Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation

Tanabe, K.; Ishida, H.; Omoto, K.; Shimizu, T.; Shirakawa, H., 2008:
Antibody-mediated rejection: a single center experience at Tokyo Women's Medical University

Arias, M.; Rush, D.N.; Wiebe, C.; Gibson, I.W.; Blydt-Hansen, T.D.; Nickerson, P.W.; Sellarés, J.; López-Hoyos, M.; San Segundo, D.; Crespo-Leiro, Mía.G.; Marzoa-Rivas, R.; Barge-Caballero, E.; Paniagua-Martín, Mía.J.; Román, A.; Serón, D.; Böhmig, G.; Schwaiger, E., 2014:
Antibody-mediated rejection: analyzing the risk, proposing solutions

Baldwin, W.M.; Valujskikh, A.; Fairchild, R.L., 2010:
Antibody-mediated rejection: emergence of animal models to answer clinical questions

Khan, T.Toufeeq.; Mirza, A.Baig.; Zahid, R.; Haleem, A.; Al Hussaini, H.; Al Sulaiman, M.; Mousa, D., 2011:
Antibody-mediated rejection: importance of lactate dehydrogenase and neutrophilia in early diagnosis

Singh, N.; Pirsch, J.; Samaniego, M., 2008:
Antibody-mediated rejection: treatment alternatives and outcomes

Wan, R.; Ying, W.; Zeng, L.; Deng, X.; Chen, H.; Gao, L., 2011:
Antibody-mediated response in rat liver chronic rejection

Li, Y.; Smith, D.; Li, Q.; Sheibani, N.; Huang, S.; Kern, T.; Nagaraj, R.H.; Lin, F., 2012:
Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy

Geronimo, C.Lay.A.; MacCuspie, R.I., 2011:
Antibody-mediated self-limiting self-assembly for quantitative analysis of nanoparticle surfaces by atomic force microscopy

Bilyy, R.; Tomin, A.; Mahorivska, I.; Shalay, O.; Lohinskyy, V.; Stoika, R.; Kit, Y., 2011:
Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma

Brase, J.C.; Mannsperger, H.; Sültmann, H.; Korf, U., 2012:
Antibody-mediated signal amplification for reverse phase protein array-based protein quantification

Holzer, F.Josef.; Rossetti, A.O.; Heritier-Barras, A-Chantal.; Zumsteg, D.; Roebling, R.; Huber, R.; Lerche, H.; Kiphuth, I.C.; Bardutzky, Jürgen.; Bien, C.G.; Tröger, M.; Schoch, G.; Prüss, H.; Seeck, M., 2013:
Antibody-mediated status epilepticus: a retrospective multicenter survey

Zhong, L.; Haynes, L.; Struble, E.Budo.; Tamin, A.; Virata-Theimer, M.Luisa.; Zhang, P., 2009:
Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein

Cao, H.; Zhang, G-Rong.; Geller, A.I., 2011:
Antibody-mediated targeted gene transfer to NMDA NR1-containing neurons in rat neocortex by helper virus-free HSV-1 vector particles containing a chimeric HSV-1 glycoprotein C-staphylococcus A protein

Xia, C-Fang.; Boado, R.J.; Pardridge, W.M., 2009:
Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology

Cox, J.H.; Hussell, S.; Søndergaard, H.; Roepstorff, K.; Bui, J-Vu.; Deer, J.Running.; Zhang, J.; Li, Z-Guo.; Lamberth, K.; Kvist, P.Helding.; Padkjær, Søren.; Haase, C.; Zahn, S.; Odegard, V.H., 2014:
Antibody-mediated targeting of the Orai1 calcium channel inhibits T cell function

Lund, I.K.; Jögi, A.; Rønø, B.; Rasch, M.G.; Lund, L.R.; Almholt, K.; Gårdsvoll, H.; Behrendt, N.; Rømer, J.; Høyer-Hansen, G., 2008:
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo

Nguan, C., 2013:
Antibody-mediated vascular rejection of kidney allografts: a population-based study

Nankivell, B.J., 2013:
Antibody-mediated vascular rejection: relation to causation

Pierson, R.N., 2009:
Antibody-mediated xenograft injury: mechanisms and protective strategies

Newa, M.; Bhandari, K.Hari.; Tang, L.; Kalvapalle, R.; Suresh, M.; Doschak, M.R., 2011:
Antibody-mediated "universal" osteoclast targeting platform using calcitonin as a model drug

Yu, B.; Wages, J.M.; Larrick, J.W., 2015:
Antibody-membrane switch (AMS) technology for facile cell line development

Zhou, X.; Zhou, J., 2008:
Antibody-microarrays on hybrid polymeric thin film-coated slides for multiple-protein immunoassays

Olivier, G.K.; Cho, A.; Sanii, B.; Connolly, M.D.; Tran, H.; Zuckermann, R.N., 2014:
Antibody-mimetic peptoid nanosheets for molecular recognition

Maus, M.V.; Grupp, S.A.; Porter, D.L.; June, C.H., 2014:
Antibody-modified T cells: CARs take the front seat for hematologic malignancies

Okamoto, A.; Asai, T.; Kato, H.; Ando, H.; Minamino, T.; Mekada, E.; Oku, N., 2014:
Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGF

Torchilin, V., 2008:
Antibody-modified liposomes for cancer chemotherapy

Blackburn, D.; Highley, J.Robin.; Wharton, S.; Romanowski, C.; Bowen, J.; Sharrack, B., 2009:
Antibody-negative neuromyelitis optica with heavy B-cell infiltration

Donati, M.; Di Francesco, A.; Delucca, F.; Di Paolo, M.; Battilani, M.; Balboni, A.; Baldelli, R.; Cevenini, R., 2011:
Antibody-neutralizing activity against all urogenital Chlamydia trachomatis serovars in Chlamydia suis-infected pigs

Rybak, S.M., 2008:
Antibody-onconase conjugates: cytotoxicity and intracellular routing

Evoli, A., 2008:
Antibody-phenotype correlation in stiff-person syndrome

Burbelo, P.D.; Ching, K.H.; Bush, E.R.; Han, B.L.; Iadarola, M.J., 2010:
Antibody-profiling technologies for studying humoral responses to infectious agents

Jin, T.; Tiwari, D.K.; Tanaka, S-Ichi.; Inouye, Y.; Yoshizawa, K.; Watanabe, T.M., 2011:
Antibody-protein A conjugated quantum dots for multiplexed imaging of surface receptors in living cells

Steiner, M.; Neri, D., 2012:
Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends

Duquesnoy, R.J., 2011:
Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications

McEnaney, P.J.; Parker, C.G.; Zhang, A.X.; Spiegel, D.A., 2013:
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease

Tanaka, K., 2012:
Antibody-related neuroimmunological disorders: update on the diagnosis and treatment

Doria-Rose, N.A.; Connors, M., 2010:
Antibody-secreting B cells in HIV infection

Rahman, A.; Rashu, R.; Bhuiyan, T.Rahman.; Chowdhury, F.; Khan, A.Islam.; Islam, K.; LaRocque, R.C.; Ryan, E.T.; Wrammert, J.; Calderwood, S.B.; Qadri, F.; Harris, J.B., 2014:
Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh

Maier-Moore, J.S.; Koelsch, K.A.; Smith, K.; Lessard, C.J.; Radfar, L.; Lewis, D.; Kurien, B.T.; Wolska, N.; Deshmukh, U.; Rasmussen, A.; Sivils, K.L.; James, J.A.; Farris, A.Darise.; Scofield, R.Hal., 2015:
Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome

Yoshida, Y.; Horii, K.; Sakai, N.; Masuda, H.; Furuichi, M.; Waga, I., 2010:
Antibody-specific aptamer-based PCR analysis for sensitive protein detection

Katzav, A.; Ben-Ziv, T.; Blank, M.; Pick, C.G.; Shoenfeld, Y.; Chapman, J., 2014:
Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice

Li, Y.; Wang, H.; Oosterwijk, E.; Selman, Y.; Mira, J.C.; Medrano, T.; Shiverick, K.T.; Frost, S.C., 2009:
Antibody-specific detection of CAIX in breast and prostate cancers

Zhao, L.; Wong, L.; Li, J., 2012:
Antibody-specified B-cell epitope prediction in line with the principle of context-awareness

Tsuji, T.; Matsuzaki, J.; Kelly, M.P.; Ramakrishna, V.; Vitale, L.; He, L-Zhen.; Keler, T.; Odunsi, K.; Old, L.J.; Ritter, G.; Gnjatic, S., 2011:
Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity

Krauss, Jürgen.; Arndt, M.A.E.; Dübel, S.; Rybak, S.M., 2008:
Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy

Dalmazzo, L.F.F.; Santana-Lemos, Bárbara.A.; Jácomo, R.H.; Garcia, A.B.; Rego, E.M.; da Fonseca, L.M.; Falcão, R.P., 2011:
Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies

Gao, J.; Chen, H.; Song, H.; Su, X.; Niu, F.; Li, W.; Li, B.; Dai, J.; Wang, H.; Guo, Y., 2014:
Antibody-targeted immunoliposomes for cancer treatment

Sofou, S.; Sgouros, G., 2008:
Antibody-targeted liposomes in cancer therapy and imaging

Fay, F.; Scott, C.J., 2012:
Antibody-targeted nanoparticles for cancer therapy

Sharpe, M.A.; Marcano, D.C.; Berlin, J.M.; Widmayer, M.A.; Baskin, D.S.; Tour, J.M., 2012:
Antibody-targeted nanovectors for the treatment of brain cancers

Kaur, P.; Qiang-Fu; Fuhrmann, A.; Ros, R.; Kutner, L.Obenauer.; Schneeweis, L.A.; Navoa, R.; Steger, K.; Xie, L.; Yonan, C.; Abraham, R.; Grace, M.J.; Lindsay, S., 2011:
Antibody-unfolding and metastable-state binding in force spectroscopy and recognition imaging

Nishida, Y.; Aida, K.; Kihara, M.; Kobayashi, T., 2015:
Antibody-validated proteins in inflamed islets of fulminant type 1 diabetes profiled by laser-capture microdissection followed by mass spectrometry

Cottingham, K., 2008:
Antibodypedia seeks to answer the question: "how good is that antibody?"

Björling, E.; Uhlén, M., 2008:
Antibodypedia, a portal for sharing antibody and antigen validation data

Wang, S-Guang.; Qiu, Y-Xiang.; Schwarz, W.H.Eugen., 2010:
Antibond breaking--the formation and decomposition of He@adamantane: descriptions, explanations, and meaning of concepts

Doty, M.F.; Climente, J.I.; Korkusinski, M.; Scheibner, M.; Bracker, A.S.; Hawrylak, P.; Gammon, D., 2009:
Antibonding ground states in InAs quantum-dot molecules

Grzelczak, M.; Mezzasalma, S.A.; Ni, W.; Herasimenka, Y.; Feruglio, L.; Montini, T.; Pérez-Juste, J.; Fornasiero, P.; Prato, M.; Liz-Marzán, L.M., 2012:
Antibonding plasmon modes in colloidal gold nanorod clusters

Zeng, W-Cai.; Jia, L-Rong.; Zhang, Y.; Cen, J-Qi.; Chen, X.; Gao, H.; Feng, S.; Huang, Y-Na., 2011:
Antibrowning and antimicrobial activities of the water-soluble extract from pine needles of Cedrus deodara

Fan, X.; Sokorai, K.J.B.; Liao, C-Hsing.; Cooke, P.; Zhang, H.Q., 2010:
Antibrowning and antimicrobial properties of sodium acid sulfate in apple slices

Zocca, F.; Lomolino, G.; Lante, A., 2010:
Antibrowning potential of Brassicacaea processing water

Scheid, B.; Dorbolo, Séphane.; Arriaga, L.R.; Rio, E., 2013:
Antibubble dynamics: the drainage of an air film with viscous interfaces

Allahbadia, G.N.; Gandhi, G.; Kadam, K.; Arora, S.; Awasthi, A.; Nagwekar, A.; Allahbadia, S.; Wolman, I., 2008:
Antibubble trajectory during embryo transfers in donor egg IVF does not predict success

Ryan, W.; Smith, J.David., 2009:
Antibullying programs in schools: how effective are evaluation practices?

Egues, A.L.; Leinung, E.Z., 2015:
Antibullying workshops: shaping minority nursing leaders through curriculum innovation

Huang, Y-Ping.; Kumar, P., 2012:
Antibunched emission of photon pairs via quantum Zeno blockade

Carmele, A.; Richter, M.; Chow, W.W.; Knorr, A., 2010:
Antibunching of thermal radiation by a room-temperature phonon bath: a numerically solvable model for a strongly interacting light-matter-reservoir system

Yuan, C.T.; Yu, P.; Ko, H.C.; Huang, J.; Tang, J., 2009:
Antibunching single-photon emission and blinking suppression of CdSe/ZnS quantum dots

Woods, D., 1982:
Antibusiness attitudes strangling drug research

Thiene, G.; Valente, M., 2011:
Anticalcification strategies to increase bioprosthetic valve durability

Tulunay Kaya, C.; Sinan Ertas, F.; Hasan, T.; Candemir, B.; Ozdol, C.; Arikan Akan, O.; Kocum, T.; Dincer, I.; Sahin, M.; Atmaca, Y.; Conkbayır, C.; Erol, C., 2011:
Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcification

Schiff, T., 2007:
Anticalculus effect of a cetylpyridinium chloride/zinc gluconate mucoadhesive gel: results of a randomized, double-blind, controlled clinical trial

Grases, F.; Perelló, J.; Sanchis, P.; Isern, B.; Prieto, R.M.; Costa-Bauzá, A.; Santiago, C.; Ferragut, M.L.; Frontera, G., 2008:
Anticalculus effect of a triclosan mouthwash containing phytate: a double-blind, randomized, three-period crossover trial

Llena, C.; Forner, L.; Vento, C., 2009:
Anticalculus efficacy of a new dentifrice

Skerra, A., 2007:
Anticalins as alternative binding proteins for therapeutic use

Gebauer, M.; Skerra, A., 2012:
Anticalins small engineered binding proteins based on the lipocalin scaffold

Richter, A.; Eggenstein, E.; Skerra, A., 2014:
Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins

Hohlbaum, A.M.; Skerra, A., 2007:
Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies

Schimler, S.D.; Hall, D.J.; Debbert, S.L., 2013:
Anticancer (hexacarbonyldicobalt)propargyl aryl ethers: synthesis, antiproliferative activity, apoptosis induction, and effect on cellular oxidative stress

Chinthala, Y.; Chinde, S.; Kumar, A.Niranjana.; Srinivas, K.V.N.Satya.; Kumar, J.Kotesh.; Sastry, K.Pandu.; Grover, P.; Ramana, M.Venkat., 2014:
Anticancer Active Homoisoflavone from the Underground Bulbs of Ledebouria hyderabadensis

Medvetz, D.A.; Hindi, K.M.; Panzner, M.J.; Ditto, A.J.; Yun, Y.H.; Youngs, W.J., 2008:
Anticancer Activity of Ag(I) N-Heterocyclic Carbene Complexes Derived from 4,5-Dichloro-1H-Imidazole

Berrington, D.; Lall, N., 2012:
Anticancer Activity of Certain Herbs and Spices on the Cervical Epithelial Carcinoma (HeLa) Cell Line

Amjadi, I.; Rabiee, M.; Hosseini, M-Sadat., 2014:
Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation

Wyrębska, A.; Gach, K.; Lewandowska, U.; Szewczyk, K.; Hrabec, Eżbieta.; Modranka, J.; Jakubowski, Rł.; Janecki, T.; Szymański, J.; Janecka, A., 2015:
Anticancer Activity of New Synthetic α-Methylene-δ-Lactones on Two Breast Cancer Cell Lines

Jo, S-Kyoung.; Hong, J-Young.; Park, H.Joo.; Lee, S.Kook., 2013:
Anticancer Activity of Novel Daphnane Diterpenoids from Daphne genkwa through Cell-Cycle Arrest and Suppression of Akt/STAT/Src Signalings in Human Lung Cancer Cells

Mishra, A.; Jung, H.; Park, J.Woo.; Kim, H.Kyeung.; Kim, H.; Stang, P.J.; Chi, K-Whan., 2012:
Anticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a New Unsymmetrical Amide Ligand

Cutillas, N.; Martínez, A.; Yellol, G.S.; Rodríguez, V.; Zamora, A.; Pedreño, Mónica.; Donaire, A.; Janiak, C.; Ruiz, Jé., 2014:
Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity

Rosselet, A., 1948:
Anticancer Centre Romand of the townships of Fribourg, Neuchatel, Valais and Vaud; report for the year 1947

Gehdoo, R.P., 2009:
Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts)

Hwang, T.; Han, H.Dong.; Song, C.Kil.; Seong, H.; Kim, J.Hyun.; Chen, X.; Shin, B.Cheol., 2007:
Anticancer Drug-Phospholipid Conjugate for Enhancement of Intracellular Drug Delivery

Viral, D.; Shivanand, P.; Jivani, N., 2011:
Anticancer Evaluation of Adiantum venustum Don

Mishra, T.; Khullar, M.; Bhatia, A., 2010:
Anticancer Potential of Aqueous Ethanol Seed Extract of Ziziphus mauritiana against Cancer Cell Lines and Ehrlich Ascites Carcinoma

Paul, S.; Bhattacharyya, S.Sundar.; Boujedaini, N.; Khuda-Bukhsh, A.Rahman., 2010:
Anticancer Potentials of Root Extract of Polygala senega and Its PLGA Nanoparticles-Encapsulated Form

Parson, C.; Smith, V.; Krauss, C.; Banerjee, H.N.; Reilly, C.; Krause, J.A.; Wachira, J.M.; Giri, D.; Winstead, A.; Mandal, S.K., 2014:
Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines

Grabacka, M.; Reiss, K., 2008:
Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation

Simpson-Haidaris, P.J.; Pollock, S.J.; Ramon, S.; Guo, N.; Woeller, C.F.; Feldon, S.E.; Phipps, R.P., 2010:
Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

Qamar, S.; Carrasquer, C.Alex.; Cunningham, S.L.; Cunningham, A.R., 2011:
Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines

Raj, G.Gowtham.; Varghese, H.Sara.; Kotagiri, S.; Vrushabendra Swamy, B.M.; Swamy, A.; Pathan, R.Khan., 2014:
Anticancer Studies of Aqueous Extract of Roots and Leaves of Pandanus Odoratissimus f. ferreus (Y. Kimura) Hatus: An In Vitro Approach

Lu, Y.; Wang, Q.; Yi, Q., 2014:
Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy

Ahmad, A.; Sarkar, S.H.; Aboukameel, A.; Ali, S.; Biersack, B.; Seibt, S.; Li, Y.; Bao, B.; Kong, D.; Banerjee, S.; Schobert, R.; Padhye, S.B.; Sarkar, F.H., 2013:
Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling

Han, S.Wei.; Roman, J., 2010:
Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer

Yu, W.; Jia, L.; Park, S-Kyung.; Li, J.; Gopalan, A.; Simmons-Menchaca, M.; Sanders, B.G.; Kline, K., 2010:
Anticancer actions of natural and synthetic vitamin E forms: RRR-alpha-tocopherol blocks the anticancer actions of gamma-tocopherol

Wendel, M.; Heller, A.R., 2009:
Anticancer actions of omega-3 fatty acids--current state and future perspectives

Schobert, R.; Knauer, S.; Seibt, S.; Biersack, B., 2011:
Anticancer active illudins: recent developments of a potent alkylating compound class

Plengsuriyakarn, T.; Viyanant, V.; Eursitthichai, V.; Picha, P.; Kupradinun, P.; Itharat, A.; Na-Bangchang, K., 2012:
Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models

Lu, D-Yong.; Lu, T-Ren., 2010:
Anticancer activities and mechanisms of bisdioxopiperazine compounds probimane and MST-16

de Pace, R.Castillo.Cohen.; Liu, X.; Sun, M.; Nie, S.; Zhang, J.; Cai, Q.; Gao, W.; Pan, X.; Fan, Z.; Wang, S., 2014:
Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells

Khan, M.Asaduzzaman.; Chen, H-chun.; Tania, M.; Zhang, D-zheng., 2013:
Anticancer activities of Nigella sativa (black cumin)

Dong, J-Tang., 2013:
Anticancer activities of PPARγ in breast cancer are context-dependent

Shinohara, K-Ichi.; Bando, T.; Sugiyama, H., 2010:
Anticancer activities of alkylating pyrrole-imidazole polyamides with specific sequence recognition

Hui, C.; Bin, Y.; Xiaoping, Y.; Long, Y.; Chunye, C.; Mantian, M.; Wenhua, L., 2011:
Anticancer activities of an anthocyanin-rich extract from black rice against breast cancer cells in vitro and in vivo

Hsiao, Y-Cheng.; Wang, K-Shiuan.; Tsai, S-Huai.; Chao, W-Ting.; Lung, F-Di.T., 2014:
Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide

Huang, C.; Zhu, Y.; Jiang, Y.; Li, Z.; Yao, J.; Duan, G.; Li, D.; Wang, Q., 2013:
Anticancer activities of anti-membrane antibodies against colon carcinoma cells undergoing chemotherapy

Firestone, G.L.; Sundar, S.N., 2009:
Anticancer activities of artemisinin and its bioactive derivatives

Wang, L.; Wang, J.; Fang, L.; Zheng, Z.; Zhi, D.; Wang, S.; Li, S.; Ho, C-Tang.; Zhao, H., 2015:
Anticancer activities of citrus peel polymethoxyflavones related to angiogenesis and others

Wang, T.; Yuan, Y.; Wang, J.; Han, C.; Chen, G., 2012:
Anticancer activities of constituents from the stem of Polyalthia rumphii

Neto, C.C.; Amoroso, J.W.; Liberty, A.M., 2008:
Anticancer activities of cranberry phytochemicals: an update

Wang, W.; Zhang, B.; Chen, H.; Zhang, L., 2010:
Anticancer activities of curcumin on human hepatocarcinoma cell line Sk-hep-1

Lesgards, J-François.; Baldovini, N.; Vidal, N.; Pietri, S., 2015:
Anticancer activities of essential oils constituents and synergy with conventional therapies: a review

Hörmann, V.; Kumi-Diaka, J.; Durity, M.; Rathinavelu, A., 2014:
Anticancer activities of genistein-topotecan combination in prostate cancer cells

Huang, W-Hua.; Shao, L.; Wang, C-Zhi.; Yuan, C-Su.; Zhou, H-Hao., 2014:
Anticancer activities of polyynes from the root bark of Oplopanax horridus and their acetylated derivatives

Nikhil, K.; Sharan, S.; Singh, A.K.; Chakraborty, A.; Roy, P., 2015:
Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγ

Shrestha, G.; El-Naggar, A.M.; S.C.air, L.L.; O'Neill, K.L., 2015:
Anticancer activities of selected species of North American lichen extracts

Ma, G.; Chong, L.; Li, Z.; Cheung, A.H.T.; Tattersall, M.H.N., 2008:
Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro

Kuete, V.; Wabo, H.K.; Eyong, K.O.; Feussi, M.T.; Wiench, B.; Krusche, B.; Tane, P.; Folefoc, G.N.; Efferth, T., 2012:
Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants

DU, J.; Guo, Y.; Bao, Y.; Xing, M.; Mahmoud, A.M.; Che, Z.; Chen, Z.; Yang, W., 2014:
Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling

Ma, H.; Fan, Q.; Yu, J.; Xin, J.; Zhang, C., 2014 :
Anticancer activities of tanshinone microemulsion against hepatocellular carcinoma in vitro and in vivo

Manosroi, A.; Jantrawut, P.; Sainakham, M.; Manosroi, W.; Manosroi, J., 2013:
Anticancer activities of the extract from Longkong (Lansium domesticum) young fruits

Srivastava, R.S.; Fronczek, F.R.; Perkins, R.S.; Fukuyama, T.; Xu, W., 2010:
Anticancer activities of the ruthenium carboxylato, amido and pyridine complexes

Norikura, T.; Fujiwara, K.; Narita, T.; Yamaguchi, S.; Morinaga, Y.; Iwai, K.; Matsue, H., 2011:
Anticancer activities of thelephantin O and vialinin A isolated from Thelephora aurantiotincta

Busto, N.; Valladolid, Jús.; Martínez-Alonso, M.; Lozano, Héctor.J.; Jalón, Félix.A.; Manzano, B.R.; Rodríguez, A.M.; Carrión, M.Carmen.; Biver, T.; Leal, Jé.M.; Espino, G.; García, Bña., 2014:
Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand

Zhu, T.; Wang, Y.; Ding, W.; Xu, J.; Chen, R.; Xie, J.; Zhu, W.; Jia, L.; Ma, T., 2015:
Anticancer activity and DNA-binding investigations of the Cu(II) and Ni(II) complexes with coumarin derivative

Jamshidi, M.; Yousefi, R.; Nabavizadeh, S.Masoud.; Rashidi, M.; Haghighi, M.Golbon.; Niazi, A.; Moosavi-Movahedi, A-Akbar., 2014:
Anticancer activity and DNA-binding properties of novel cationic Pt(II) complexes

Sandra, C-Maya.; Eduardo, C.Cortes.; Simon, H-Ortega.; Teresa, R.Apan.; Antonio, N.Camacho.; Lijanova, I.V.; Marcos, M-Garcia., 2013:
Anticancer activity and anti-inflammatory studies of 5-aryl-1,4-benzodiazepine derivatives

Mollah, M.Lalmoddin.; Song, J-Chan.; Park, C-Ho.; Lee, G-Dong.; Hong, J-Heon.; Ryoo, Z.Young.; Lee, S.; Chang, K-Tae.; Kim, K-Soo., 2010:
Anticancer activity and apoptotic effects of Bulnesia sarmienti against human lung cancer H460 cells

Beckford, F.A.; Thessing, J.; Stott, A.; Holder, A.A.; Poluektov, O.G.; Li, L.; Seeram, N.P., 2013:
Anticancer activity and biophysical reactivity of copper complexes of 2-(benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides

Caba, O.; Díaz-Gavilán, Mónica.; Rodríguez-Serrano, F.; Boulaiz, H.; Aránega, A.; Gallo, M.A.; Marchal, J.A.; Campos, Jín.M., 2012:
Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine

Boddupally, P.V.L.; Hahn, S.; Beman, C.; De, B.; Brooks, T.A.; Gokhale, V.; Hurley, L.H., 2012:
Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter

Click, R.E., 2013:
Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems

Shin, H.Cheol.; Song, D.Won.; Baek, W.Ki.; Lee, S.Ryong.; Kwon, T.Kyu.; Lee, J.; Park, S.Hee.; Jang, B-Churl.; Park, J-Wook., 2009:
Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor

Zhang, W.; Liu, A.; Li, Y.; Zhao, X.; Lv, S.; Zhu, W.; Jin, Y., 2013:
Anticancer activity and mechanism of juglone on human cervical carcinoma HeLa cells

Zhang, X.Yan.; Lian Yan, X.; Guo, W.; Xu, B.; Li, M.; Zhou, Y.; Rong Cui, J., 2009:
Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells

Olszewski, U.; Claffey, J.; Hogan, M.; Tacke, M.; Zeillinger, R.; Bednarski, P.J.; Hamilton, G., 2011:
Anticancer activity and mode of action of titanocene C

Guo, L.; Peng, Y.; Yao, J.; Sui, L.; Gu, A.; Wang, J., 2011:
Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice

Mengesha, A.Endale.; Youan, B-Botti.C., 2011:
Anticancer activity and nutritional value of extracts of the seed of Glinus lotoides

Liu, S.; Zhang, J.; Li, D.; Liu, W.; Luo, X.; Zhang, R.; Li, L.; Zhao, J., 2007:
Anticancer activity and quantitative analysis of flavone of Cirsium japonicum DC

Pontiki, E.; Hadjipavlou-Litina, D.; Geromichalos, G.; Papageorgiou, A., 2009:
Anticancer activity and quantitative-structure activity relationship (QSAR) studies of a series of antioxidant/anti-inflammatory aryl-acetic and hydroxamic acids

Wang, L.; Zheng, C.; Liu, Y.; Le, F.; Yang, F.; Qin, X.; Wang, C.; Liu, J., 2014:
Anticancer activity for targeting telomeric G-quadruplex and antiangiogenesis of a novel Ru(II)-Se complex

Liu, P.; Xu, S.; Zhang, M.; Wang, W.Wen.; Zhang, Y.Fang.; Rehman, K.; Naranmandura, H.; Chen, Z., 2014:
Anticancer activity in human multiple myeloma U266 cells: synergy between cryptotanshinone and arsenic trioxide

Wang, O.; Liu, S.; Zou, J.; Lu, L.; Chen, L.; Qiu, S.; Li, H.; Lu, X., 2011:
Anticancer activity of 2α, 3α, 19β, 23β-Tetrahydroxyurs-12-en-28-oic acid (THA), a novel triterpenoid isolated from Sinojackia sarcocarpa

Ahmad, F.Bin.H.; Ghaffari Moghaddam, M.; Basri, M.; Abdul Rahman, M.Basyaruddin., 2010:
Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis

Sakthivel, K.M.; Kannan, N.; Angeline, A.; Guruvayoorappan, C., 2013:
Anticancer activity of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica against Dalton's ascitic lymphoma induced solid and ascitic tumor model

Wang, H-Qian.; Li, D-Li.; Lu, Y-Jing.; Cui, X-Xing.; Zhou, X-Fen.; Lin, W-Ping.; Conney, A.H.; Zhang, K.; Du, Z-Yun.; Zheng, X., 2015:
Anticancer activity of Acanthopanax trifoliatus (L) Merr extracts is associated with inhibition of NF-kB activity and decreased Erk1/2 and Akt phosphorylation

Jiao, C.; Xie, Y-Zhen.; Yang, X.; Li, H.; Li, X-Min.; Pan, H-Hui.; Cai, M-Hua.; Zhong, H-Mei.; Yang, B.B., 2014:
Anticancer activity of Amauroderma rude

Pai, K.S.R.; Srilatha, P.; Suryakant, K.; Setty, M.Manjunath.; Nayak, P.G.; Rao, C.Mallikarjuna.; Baliga, M.S., 2012:
Anticancer activity of Berberis aristata in Ehrlich ascites carcinoma-bearing mice: a preliminary study

Drygin, D.; Siddiqui-Jain, A.; O'Brien, S.; Schwaebe, M.; Lin, A.; Bliesath, J.; Ho, C.B.; Proffitt, C.; Trent, K.; Whitten, J.P.; Lim, J.K.C.; Von Hoff, D.; Anderes, K.; Rice, W.G., 2009:
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis

Raja, S.M.; Clubb, R.J.; Ortega-Cava, C.; Williams, S.H.; Bailey, T.A.; Duan, L.; Zhao, X.; Reddi, A.L.; Nyong, A.M.; Natarajan, A.; Band, V.; Band, H., 2011:
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers

Thavamani, B.Samuel.; Mathew, M.; Palaniswamy, D.S., 2015:
Anticancer activity of Cocculus hirsutus against Dalton's lymphoma ascites (DLA) cells in mice

Lee, J.Ha.; Kim, I-Woo.; Kim, S-Hee.; Yun, E-Young.; Nam, S-Hee.; Ahn, M-Young.; Kang, D-Chul.; Hwang, J.Sam., 2016:
Anticancer activity of CopA3 dimer peptide in human gastric cancer cells

Geng, D.; Duan, Y-Long.; Xu, X-Lin.; Wang, C-Mei.; Cui, X-Dong.; Ouyang, Z.; Chen, B., 2016:
Anticancer activity of Crocodylus siamensis blood in vitro and in vivo

Mayakrishnan, V.; Kannappan, P.; Shanmugasundaram, K.; Abdullah, N., 2015:
Anticancer activity of Cyathula prostrata (Linn) Blume against Dalton's lymphomae in mice model

Salem, T.A.; Ibrahim, A.M., 2011:
Anticancer activity of Egyptian marine alga Ulva rigida

van Meeteren, L.A.; Brinkmann, V.; Saulnier-Blache, J.Sébastien.; Lynch, K.R.; Moolenaar, W.H., 2008:
Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D

Sankar, R.; Maheswari, R.; Karthik, S.; Shivashangari, K.Subramanian.; Ravikumar, V., 2015:
Anticancer activity of Ficus religiosa engineered copper oxide nanoparticles

Ryu, Y-Lim.; Jung, K.Hee.; Son, M.Kwon.; Yan, H.Hua.; Kim, S.Jung.; Shin, S.; Hong, S.; Hong, S-Sun., 2014:
Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells

Yang, G.; Wang, Z.; Wang, W.; Zhou, X.; Hu, X.; Yang, J., 2015:
Anticancer activity of Luteolin and its synergism effect with BCG on human bladder cancer cell line BIU-87

Huang, H-Li.; Huang, H-Lin.; Lee, H-Yun.; Tsai, A-Chi.; Peng, C-Yu.; Lai, M-Jung.; Wang, J-Chi.; Pan, S-Lin.; Teng, C-Ming.; Liou, J-Ping., 2013:
Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo

Vasanth, K.; Ilango, K.; MohanKumar, R.; Agrawal, A.; Dubey, G.Prasad., 2014:
Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction

Luzina, E.L.; Popov, A.V., 2011:
Anticancer activity of N-bis(trifluoromethyl)alkyl-N'-(polychlorophenyl) and N'-(1,2,4-triazolyl) ureas

Randhawa, M.Akram.; Alghamdi, M.Safar., 2012:
Anticancer activity of Nigella sativa (black seed) - a review

Chougule, M.; Patel, A.R.; Sachdeva, P.; Jackson, T.; Singh, M., 2011:
Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer

Chen, P.; Zhao, S-Hai.; Chu, Y-Lie.; Xu, K.; Zhu, L.; Wu, Y.; Song, J.; Cao, C-Xia.; Xue, X.; Niu, Y-Ying., 2009:
Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line

Lim, S-Ho.; Jeong, Y-Il.; Moon, K-Sub.; Ryu, H-Hwa.; Jin, Y-Hao.; Jin, S-Guang.; Jung, T-Young.; Kim, I-Young.; Kang, S-Suk.; Jung, S., 2010:
Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells

Bi, X.; Zhao, Y.; Fang, W.; Yang, W., 2010:
Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling

Farshori, N.Nayyar.; Al-Sheddi, E.Saad.; Al-Oqail, M.Mohammad.; Musarrat, J.; Al-Khedhairy, A.Ali.; Siddiqui, M.Ahmed., 2015:
Anticancer activity of Petroselinum sativum seed extracts on MCF-7 human breast cancer cells

Mahata, S.; Pandey, A.; Shukla, S.; Tyagi, A.; Husain, S.Akhtar.; Das, B.Chandra.; Bharti, A.Chandra., 2014:
Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells

Lee, Y.; Kim, H.; Lee, J.; Kim, K., 2011:
Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell

Zhao, Y.; Yu, D.; Wu, H.; Liu, H.; Zhou, H.; Gu, R.; Zhang, R.; Zhang, S.; Wu, G., 2014:
Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo

Sertel, S.; Eichhorn, T.; Plinkert, P.K.; Efferth, T., 2012:
Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)

Zandi, K.; Ahmadzadeh, S.; Tajbakhsh, S.; Rastian, Z.; Yousefi, F.; Farshadpour, F.; Sartavi, K., 2010:
Anticancer activity of Sargassum oligocystum water extract against human cancer cell lines

Anjana, A.; Ahamed, K.F.H.Nazeer.; Ravichandiran, V.; Sumithra, M.; Anbu, J., 2014:
Anticancer activity of Sargassum wightii Greville on Dalton's ascitic lymphoma

Moon, S-Min.; Yun, S.Joon.; Kook, J-Ki.; Kim, H-Joong.; Choi, M.Suk.; Park, B.Ram.; Kim, S-Gwan.; Kim, B-Ock.; Lee, S-Young.; Ahn, H.; Chun, H.Sung.; Kim, D.Kyung.; Kim, C.Sung., 2014:
Anticancer activity of Saussurea lappa extract by apoptotic pathway in KB human oral cancer cells

Sidhu, P.S.; Teske, K.; Feleke, B.; Yuan, N.Y.; Guthrie, M.L.; Fernstrum, G.B.; Vyas, N.D.; Han, L.; Preston, J.; Bogart, J.W.; Silvaggi, N.R.; Cook, J.M.; Singh, R.K.; Bikle, D.D.; Arnold, L.A., 2015:
Anticancer activity of VDR-coregulator inhibitor PS121912

Qazi, A.; Pal, J.; Maitah, M'in.; Fulciniti, M.; Pelluru, D.; Nanjappa, P.; Lee, S.; Batchu, R.B.; Prasad, M.; Bryant, C.S.; Rajput, S.; Gryaznov, S.; Beer, D.G.; Weaver, D.W.; Munshi, N.C.; Goyal, R.K.; Shammas, M.A., 2010:
Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy

Tripathi, R.; Samadder, T.; Gupta, S.; Surolia, A.; Shaha, C., 2011:
Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors

Huang, C-Hua.; Guh, J-Hwa.; Chen, G.Shiahuy.; Lu, P-Hsuan.; Chern, J-Wang., 2010:
Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways

Trombino, S.; Ferrarelli, T.; Pellegrino, M.; Ricchio, E.; Mauro, L.; Andò, S.; Picci, N.; Cassano, R., 2014:
Anticancer activity of a hydrogel containing folic acid towards MCF-7 and MDA-MB-231 cells

Saleh-Abady, M.Mirzaei.; Naderi-Manesh, H.; Alizadeh, A.; Shamsipour, F.; Balalaie, S.; Arabanian, A., 2010:
Anticancer activity of a new gonadotropin releasing hormone analogue

Toren, P.J.; Kim, S.; Pham, S.; Mangalji, A.; Adomat, H.; Guns, E.S.Tomlinson.; Zoubeidi, A.; Moore, W.; Gleave, M.E., 2015:
Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer

Jaggi, M.; Prasad, S.; Singh, A.T.; Praveen, R.; Dutt, S.; Mathur, A.; Sharma, R.; Gupta, N.; Ahuja, R.; Mukherjee, R.; Burman, A.C., 2008:
Anticancer activity of a peptide combination in gastrointestinal cancers targeting multiple neuropeptide receptors

Puoci, F.; Morelli, C.; Cirillo, G.; Curcio, M.; Parisi, O.Ilaria.; Maris, P.; Sisci, D.; Picci, N., 2012:
Anticancer activity of a quercetin-based polymer towards HeLa cancer cells

Yaacob, N.Soriani.; Hamzah, N.; Nik Mohamed Kamal, N.Nursyazni.; Zainal Abidin, S.Amalina.; Lai, C.Sheen.; Navaratnam, V.; Norazmi, M.Nor., 2011:
Anticancer activity of a sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast and prostate cancer cells in vitro

Kim, I-Woo.; Lee, J.Ha.; Kwon, Y-Nam.; Yun, E-Young.; Nam, S-Hee.; Ahn, M-Young.; Kang, D-Chul.; Hwang, J.Sam., 2014:
Anticancer activity of a synthetic peptide derived from harmoniasin, an antibacterial peptide from the ladybug Harmonia axyridis

Jahan, S.; Chaudhary, R.; Goyal, P.Kumar., 2010:
Anticancer activity of an Indian medicinal plant, Alstonia scholaris, on skin carcinogenesis in mice

Witort, E.; Lulli, M.; Carloni, V.; Capaccioli, S., 2014:
Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells

Sharma, P.R.; Mondhe, D.M.; Muthiah, S.; Pal, H.C.; Shahi, A.K.; Saxena, A.K.; Qazi, G.N., 2009:
Anticancer activity of an essential oil from Cymbopogon flexuosus

Adinolfi, B.; Romanini, A.; Vanni, A.; Martinotti, E.; Chicca, A.; Fogli, S.; Nieri, P., 2014:
Anticancer activity of anandamide in human cutaneous melanoma cells

Menon, V.; Bhat, S., 2010:
Anticancer activity of andrographolide semisynthetic derivatives

Damle, A.A.; Pawar, Y.P.; Narkar, A.A., 2013:
Anticancer activity of betulinic acid on MCF-7 tumors in nude mice

Luo, W.; Liu, C.; Zhang, R.; He, J.; Han, B., 2014:
Anticancer activity of binary toxins from Lysinibacillus sphaericus IAB872 against human lung cancer cell line A549

Gnant, M., 2012:
Anticancer activity of bisphosphonates in breast cancer

McGovern, P.E.; Christofidou-Solomidou, M.; Wang, W.; Dukes, F.; Davidson, T.; El-Deiry, W.S., 2010:
Anticancer activity of botanical compounds in ancient fermented beverages (review)

Dailey, O.D.; Wang, X.; Chen, F.; Huang, G., 2011:
Anticancer activity of branched-chain derivatives of oleic acid

Kepp, O.; Menger, L.; Vacchelli, E.; Adjemian, S.; Martins, I.; Ma, Y.; Sukkurwala, A.Qader.; Michaud, Mël.; Galluzzi, L.; Zitvogel, L.; Kroemer, G., 2012:
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects

Rapozzi, V.; Zorzet, S.; Zacchigna, M.; Della Pietra, E.; Cogoi, S.; Xodo, L.E., 2014:
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies

Fang, W.; Liu, S.; Nie, Y., 2011:
Anticancer activity of chamaejasmine: effect on tubulin protein

Salah, R.; Michaud, P.; Mati, F.; Harrat, Z.; Lounici, H.; Abdi, N.; Drouiche, N.; Mameri, N., 2013:
Anticancer activity of chemically prepared shrimp low molecular weight chitin evaluation with the human monocyte leukaemia cell line, THP-1

Thavamani, B.Samuel.; Mathew, M.; Dhanabal, S.P., 2014:
Anticancer activity of cissampelos pareira against dalton's lymphoma ascites bearing mice

Connolly, K.; Brungs, D.; Szeto, E.; Epstein, R.J., 2014:
Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAF (V600E)-mutant metastatic colorectal carcinoma

Kaluderović, M.R.; Gómez-Ruiz, S.; Gallego, B.; Hey-Hawkins, E.; Paschke, R.; Kaluderović, G.N., 2010:
Anticancer activity of dinuclear gallium(III) carboxylate complexes

Yang, S-Min.; Wu, D-Gang.; Liu, X-Kui., 2010:
Anticancer activity of diterpenoids from Amoora ouangliensis and Amoora stellato-squamosa

Aras, A.; Iqbal, M.Javed.; Naqvi, S.Kamran-Ul-Hassan.; Gercek, Y.Can.; Boztas, K.; Gasparri, M.Luisa.; Shatynska-Mytsyk, I.; Fayyaz, S.; Farooqi, A.Ahmad., 2015:
Anticancer activity of essential oils: targeting of protein networks in cancer cells

Sandra, C-Maya.; Elena, K.; Marcos, F-Alamo.; Elena, Mínez-Klimova.; Arturo, Rírez-Ramírez.; Teresa, Rírez.Apan.; Marcos, Mínez-García., 2014:
Anticancer activity of ferrocenylthiosemicarbazones

Kim, H-Jun.; Ryu, K.; Kang, J-Hee.; Choi, A-Jin.; Kim, T-il.; Oh, J-Min., 2014:
Anticancer activity of ferulic acid-inorganic nanohybrids synthesized via two different hybridization routes, reconstruction and exfoliation-reassembly

Yang, P.; Cartwright, C.; Chan, D.; Ding, J.; Felix, E.; Pan, Y.; Pang, J.; Rhea, P.; Block, K.; Fischer, S.M.; Newman, R.A., 2014:
Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation

Erharuyi, O.; Engel-Lutz, N.; Ahomafor, J.; Imieje, V.; Falodun, A.; Nebe, B.; Langer, P., 2014:
Anticancer activity of five forest crops used in African folklore: antiproliferative and pro-apoptotic effects

Fawzy, G.Ahmed.; Al-Taweel, A.Mohammad.; Perveen, S., 2014:
Anticancer activity of flavane gallates isolated from Plicosepalus curviflorus

Majewska-Wierzbicka, M.; Czeczot, H., 2013:
Anticancer activity of flavonoids

Biscaro, F.; Parisotto, E.Benedetti.; Zanette, V.Citadini.; Günther, T.Mara.Fischer.; Ferreira, E.Antonio.; Gris, E.Fortes.; Correia, Jão.Francisco.Gomes.; Pich, C.Tröger.; Mattivi, F.; Filho, D.Wilhelm.; Pedrosa, R.Curi., 2013:
Anticancer activity of flavonol and flavan-3-ol rich extracts from Croton celtidifolius latex

Pandi, M.; Manikandan, R.; Muthumary, J., 2010:
Anticancer activity of fungal taxol derived from Botryodiplodia theobromae Pat., an endophytic fungus, against 7, 12 dimethyl benz(a)anthracene (DMBA)-induced mammary gland carcinogenesis in Sprague Dawley rats

Davalli, P.; Rizzi, F.; Caporali, A.; Pellacani, D.; Davoli, S.; Bettuzzi, S.; Brausi, M.; D'Arca, D., 2012:
Anticancer activity of green tea polyphenols in prostate gland

Aguirre, J.Dafhne.; Angeles-Boza, A.M.; Chouai, A.; Turro, C.; Pellois, J-Philippe.; Dunbar, K.R., 2010:
Anticancer activity of heteroleptic diimine complexes of dirhodium: a study of intercalating properties, hydrophobicity and in cellulo activity

Lim, J-Hong.; Lee, Y-Mi.; Park, S.Ra.; Kim, D.Hye.; Lim, B.Ou., 2014:
Anticancer activity of hispidin via reactive oxygen species-mediated apoptosis in colon cancer cells

Mitra, R.; Das, S.; Shinde, S.V.; Sinha, S.; Somasundaram, K.; Samuelson, A.G., 2013:
Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles

Celia, C.; Trapasso, E.; Locatelli, M.; Navarra, M.; Ventura, C.Anna.; Wolfram, J.; Carafa, M.; Morittu, V.Maria.; Britti, D.; Di Marzio, L.; Paolino, D., 2014:
Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells

Lim, H.Kyung.; Bae, W.; Lee, H-Seung.; Jung, J., 2016:
Anticancer activity of marine sponge Hyrtios sp. extract in human colorectal carcinoma RKO cells with different p53 status

Jungwirth, U.; Kowol, C.R.; Keppler, B.K.; Hartinger, C.G.; Berger, W.; Heffeter, P., 2011:
Anticancer activity of metal complexes: involvement of redox processes

Voller, Jí.; Zatloukal, M.; Lenobel, Ré.; Dolezal, K.; Béres, T.; Krystof, Vír.; Spíchal, Lás.; Niemann, P.; Dzubák, P.; Hajdúch, Mán.; Strnad, M., 2010:
Anticancer activity of natural cytokinins: a structure-activity relationship study

El-Sayed, W.A.; El-Kosy, S.M.; Ali, O.M.; Emselm, H.M.; Abdel-Rahman, A.A.H., 2012:
Anticancer activity of new (tetrazol-5-yl)methylindole derivatives and their acyclic c-nucleoside analogs

Rashid, M.; Husain, A.; Shaharyar, M.; Sarafroz, M., 2015:
Anticancer activity of new compounds using benzimidazole as a scaffold

Nasr, T.; Bondock, S.; Youns, M., 2014:
Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives

Cao, Z.; Mendoza, J.; Kozielski, A.; Liu, X.; Dejesus, A.; Wang, Y.; Zhan, C-Guo.; Vardeman, D.; Giovanella, B., 2013:
Anticancer activity of new haloalkyl camptothecin esters against human cancer cell lines and human tumor xenografts grown in nude mice

Pluta, K.; Jeleń, Młgorzata.; Morak-Młodawska, B.; Zimecki, Mł.; Artym, J.; Kocieba, M., 2010:
Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank

Li, Z.; Sturm, S.; Svejda, B.; Höger, H.; Schraml, E.; Ingolic, E.; Siegl, V.; Stuppner, H.; Pfragner, R., 2008:
Anticancer activity of novel extracts from Cautleya gracilis (Smith) Dandy: apoptosis in human medullary thyroid carcinoma cells

Romagnoli, R.; Baraldi, P.Giovanni.; Salvador, M.Kimatrai.; Camacho, M.Encarnacion.; Balzarini, J.; Bermejo, J.; Estévez, F., 2013:
Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2,4-dione

Svejda, B.; Aguiriano-Moser, V.; Sturm, S.; Höger, H.; Ingolic, E.; Siegl, V.; Stuppner, H.; Pfragner, R., 2010:
Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith & Forrest) in human carcinoid KRJ-I Cells

Boot, A.; Brito, A.; VAN Wezel, T.; Morreau, H.; Costa, M.; Proença, F., 2014:
Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents

Adams, V.R.; Deremer, D.L.; Stevich, B.; Mattingly, C.A.; Gallt, B.; Subramanian, T.; Troutman, J.M.; Spielmann, H.Peter., 2010 :
Anticancer activity of novel unnatural synthetic isoprenoids

Sarmah, P.; Deka, R.C., 2010:
Anticancer activity of nucleoside analogues: a density functional theory based QSAR study

Mateos, R.; Pereira-Caro, G.; Bacon, J.R.; Bongaerts, R.; Sarriá, B.; Bravo, L.; Kroon, P.A., 2013:
Anticancer activity of olive oil hydroxytyrosyl acetate in human adenocarcinoma Caco-2 cells

Wang, J.; Yu, Y.; Yan, Z.; Hu, Z.; Li, L.; Li, J.; Jiang, X.; Qian, Q., 2014:
Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo

Barry, N.P.E.; Zava, O.; Furrer, J.; Dyson, P.J.; Therrien, B., 2010:
Anticancer activity of opened arene ruthenium metalla-assemblies

Barry, N.P.E.; Edafe, F.; Dyson, P.J.; Therrien, B., 2010:
Anticancer activity of osmium metalla-rectangles

Abakumova, O.Iu.; Podobed, O.V.; Beliaeva, N.F.; Tochilkin, A.I., 2013:
Anticancer activity of oxovanadium compounds

Nakachi, T.; Tabuchi, T.; Takasaki, A.; Arai, S.; Miyazawa, K.; Tomoda, A., 2010:
Anticancer activity of phenoxazines produced by bovine erythrocytes on colon cancer cells

Lee, J.Sun.; Yoon, I.Sang.; Lee, M.Sun.; Cha, E.Young.; Thuong, P.Thien.; Diep, T.Thi.; Kim, J.Ryong., 2013:
Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells

Choi, J.; Jiang, X.; Jeong, J.Boo.; Lee, S-Ho., 2015:
Anticancer activity of protocatechualdehyde in human breast cancer cells

Chiu, C.Chih.; Lin, Y.Tzu.; Sun, S.Li.; Sung, K.Hsun.; Wang, L.Fang., 2011:
Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex

Chen, K-Chou.; Hsieh, C-Lan.; Huang, K-Dar.; Ker, Y-Bee.; Chyau, C-Cherng.; Peng, R.Y., 2009:
Anticancer activity of rhamnoallosan against DU-145 cells is kinetically complementary to coexisting Polyphenolics in Psidium guajava budding leaves

Chelopo, M.P.; Pawar, S.A.; Sokhela, M.K.; Govender, T.; Kruger, H.G.; Maguire, G.E.M., 2014:
Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands

Giridharan, P.; Verekar, S.Amit.; Khanna, A.; Mishra, P.D.; Deshmukh, S.Kumar., 2012:
Anticancer activity of sclerotiorin, isolated from an endophytic fungus Cephalotheca faveolata Yaguchi, Nishim. & Udagawa

Moon, H-In.; Zee, O., 2011:
Anticancer activity of sesquiterpene lactone from plant food (Carpesium rosulatum) in human cancer cell lines

Eloy, L.; Jarrousse, A-Sophie.; Teyssot, M-Laure.; Gautier, A.; Morel, L.; Jolivalt, C.; Cresteil, T.; Roland, S., 2012:
Anticancer activity of silver-N-heterocyclic carbene complexes: caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF)

Hansen, T.; Ausbacher, D.; Zachariassen, Z.G.; Anderssen, T.; Havelkova, M.; Strøm, M.B., 2013:
Anticancer activity of small amphipathic β²,²-amino acid derivatives

Swindell, E.P.; Hankins, P.L.; Chen, H.; Miodragović, D.U.; O'Halloran, T.V., 2014:
Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes

Işikdağ, I.; Ozkay, Y.; Incesu, Z.; Akalin, Gülşen., 2012:
Anticancer activity of some bisbenzimidazoles

Jones, B.; Komarnitsky, P.; Miller, G.T.; Amedio, J.; Wallner, B.P., 2012:
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin

Mohanraj, S.; Murugan, D.; Rengarajan, A.; Rajiv, S., 2015:
Anticancer activity of starch/poly[N-(2-hydroxypropyl)methacrylamide]: biomaterial film to treat skin cancer

Côrte-Real, L.; Mendes, F.; Coimbra, J.; Morais, Tânia.S.; Tomaz, A.Isabel.; Valente, A.; Garcia, M.Helena.; Santos, I.; Bicho, M.; Marques, F., 2015:
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes

Chung, M.Ja.; Chung, C-Kwon.; Jeong, Y.; Ham, S-Shi., 2010:
Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells

Obeid, M., 2010:
Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides

Barry, N.P.E.; Edafe, F.; Therrien, B., 2011:
Anticancer activity of tetracationic arene ruthenium metalla-cycles

Chinn, D.C.; Holland, W.S.; Mack, P.C., 2014:
Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies

Sun, W.; Qiao, L.; Liu, Q.; Chen, L.; Ling, B.; Sammynaiken, R.; Yang, J., 2011:
Anticancer activity of the PR domain of tumor suppressor RIZ1

Pilarski, Rław.; Filip, B.; Wietrzyk, J.; Kuraś, Mław.; Gulewicz, K., 2011 :
Anticancer activity of the Uncaria tomentosa (Willd.) DC. preparations with different oxindole alkaloid composition

Rajesh, R.Pusphabai.; Ramasamy, M.Santhana.; Murugan, A., 2011:
Anticancer activity of the ascidian polyclinum indicum against cervical cancer cells (HeLa) mediated through apoptosis induction

Smith, B.; Land, H., 2013:
Anticancer activity of the cholesterol exporter ABCA1 gene

Li, Z.; Tanaka, H.; Galiano, F.; Glass, J., 2011:
Anticancer activity of the iron facilitator LS081

Kilian, G.; Davids, H.; Milne, P.J., 2013:
Anticancer activity of the liposome-encapsulated cyclic dipeptides, cyclo(His-Gly) and cyclo(His-Ala)

Akindele, A.J.; Mahajan, G.; Wani, Z.A.; Sharma, S.; Satti, N.K.; Adeyemi, O.O.; Mondhe, D.M.; Saxena, A.K., 2015:
Anticancer activity of the phytomedicine DAS-77

Singh, N.Kumar.; Singh, V.Pratap., 2014:
Anticancer activity of the roots of Ichnocarpus frutescens R. Br. and isolated triterpenes

Tabernero, J.; Chawla, S.P.; Kindler, H.; Reckamp, K.; Chiorean, E.Gabriela.; Azad, N.S.; Lockhart, A.Craig.; Hsu, C-Pang.; Baker, N.F.; Galimi, F.; Beltran, P.; Baselga, Jé., 2015:
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab

Liu, P-xun.; Gao, J.; Chen, Y-jie.; Long, W.; Shen, X.; Tang, W-sheng., 2011:
Anticancer activity of total flavonoids isolated from Xianhe Yanling Recipe (仙鹤延龄方)

An, Y.; Li, L.; Yang, D.; Jia, N.; Xu, C.; Wang, Q.; Wang, S.; Yuan, S., 2015:
Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors

Mazzini, F.; Betti, M.; Canonico, B.; Netscher, T.; Luchetti, F.; Papa, S.; Galli, F., 2010:
Anticancer activity of vitamin E-derived compounds in murine C6 glioma cells

Li, Q.Quentin.; Lee, R.X.; Liang, H.; Zhong, Y., 2013:
Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells

Soeksmanto, A.; Subroto, M.A.; Wijaya, H.; Simanjuntak, P., 2010:
Anticancer activity test for extracts of Sarang semut plant (Myrmecodya pendens) to HeLa and MCM-B2 cells

Zhou, D-Fang.; Chen, Q-Yun.; Qi, Y.; Fu, H-Jian.; Li, Z.; Zhao, K-Di.; Gao, J., 2011:
Anticancer activity, attenuation on the absorption of calcium in mitochondria, and catalase activity for manganese complexes of N-substituted di(picolyl)amine

Chanda, D.; Bhushan, S.; Guru, S.K.; Shanker, K.; Wani, Z.A.; Rah, B.A.; Luqman, S.; Mondhe, D.M.; Pal, A.; Negi, A.S., 2013:
Anticancer activity, toxicity and pharmacokinetic profile of an indanone derivative

Yeh, C-Hua.; Chou, W.; Chu, C-Chen.; So, E.Cheung.; Chang, H-Chia.; Wang, J-Joung.; Hsing, C-Hsi., 2012:
Anticancer agent 2-methoxyestradiol improves survival in septic mice by reducing the production of cytokines and nitric oxide

Poljakova, J.; Hrebackova, J.; Dvorakova, M.; Moserova, M.; Eckschlager, T.; Hrabeta, J.; Göttlicherova, M.; Kopejtkova, B.; Frei, E.; Kizek, R.; Stiborova, M., 2012:
Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma

Wu, H.; Xie, J.; Pan, Q.; Wang, B.; Hu, D.; Hu, X., 2013:
Anticancer agent shikonin is an incompetent inducer of cancer drug resistance

Savran, B.; Yerlikaya, A.; Erdoğan, E.; Genç, O., 2014:
Anticancer agent ukrain and bortezomib combination is synergistic in 4T1 breast cancer cells

Liu, Y.; Gao, X.; Deeb, D.; Arbab, A.S.; Dulchavsky, S.A.; Gautam, S.C., 2012:
Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation

Breton, D.; Jandard, V.; Cauet, Aélie.; Ginestet, Hélène.; Paillet, M.; Galvez, O.; Bohand, X., 2010:
Anticancer agents and risks for the nursing personnel

Liu, E-Hu.; Qi, L-Wen.; Wu, Q.; Peng, Y-Bo.; Li, P., 2010:
Anticancer agents derived from natural products

Bartzatt, R., 2012:
Anticancer agents for treatment of tumors in the central nervous system by correspondent substituent substitution and elucidation by pattern recognition methods

Ye, J.; Zhou, F.; Al-Kareef, A.M.Q.; Wang, H., 2015:
Anticancer agents from marine sponges

Dong, L.; Schill, H.; Grange, R.L.; Porzelle, A.; Johns, J.P.; Parsons, P.G.; Gordon, V.A.; Reddell, P.W.; Williams, C.M., 2010:
Anticancer agents from the Australian tropical rainforest: Spiroacetals EBC-23, 24, 25, 72, 73, 75 and 76

Granchi, C.; Minutolo, F., 2012:
Anticancer agents that counteract tumor glycolysis

Levêque, D., 2012:
Anticancer agents: has the maximal tolerated price been reached?

Baunbaek, D.; Trinkler, N.; Ferandin, Y.; Lozach, O.; Ploypradith, P.; Rucirawat, S.; Ishibashi, F.; Iwao, M.; Meijer, L. , 2009:
Anticancer alkaloid lamellarins inhibit protein kinases

van Blitterswijk, W.J.; Verheij, M., 2008:
Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects

Pia Schiavone, B.Immacolata.; Verotta, L.; Rosato, A.; Marilena, M.; Gibbons, S.; Bombardelli, E.; Franchini, C.; Corbo, F., 2015:
Anticancer and Antibacterial Activity of Hyperforin and Its Derivatives

Pouryasin, Z.; Yousefi, R.; Nabavizadeh, S.Masoud.; Rashidi, M.; Hamidizadeh, P.; Alavianmehr, M-Mehdi.; Moosavi-Movahedi, A.Akbar., 2014:
Anticancer and DNA binding activities of platinum (IV) complexes; importance of leaving group departure rate

Cha, Y.Jeong.; Alam, N.; Lee, J.Seong.; Lee, K.Rim.; Shim, M.Ja.; Lee, M.Woong.; Kim, H.Young.; Shin, P.Gyun.; Cheong, J.Chun.; Yoo, Y.Bok.; Lee, T.Soo., 2013:
Anticancer and Immunopotentiating Activities of Crude Polysaccharides from Pleurotus nebrodensis on Mouse Sarcoma 180

Srivastava, S.K.; Jaggi, M.; Singh, A.T.; Madan, A.; Rani, N.; Vishnoi, M.; Agarwal, S.K.; Mukherjee, R.; Burman, A.C., 2007:
Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives

Mohammadi-Motlagh, H-Reza.; Mostafaie, A.; Mansouri, K., 2012:
Anticancer and anti-inflammatory activities of shallot (Allium ascalonicum) extract

Lambert, J.D.; Sang, S.; Hong, J.; Yang, C.S., 2011:
Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate

Greish, K.; Ray, A.; Bauer, H.; Larson, N.; Malugin, A.; Pike, D.; Haider, M.; Ghandehari, H., 2011:
Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy

Bladt, T.Thorskov.; Frisvad, J.Christian.; Knudsen, P.Boldsen.; Larsen, T.Ostenfeld., 2014:
Anticancer and antifungal compounds from Aspergillus, Penicillium and other filamentous fungi

Halim, H.; Chunhacha, P.; Suwanborirux, K.; Chanvorachote, P., 2011:
Anticancer and antimetastatic activities of Renieramycin M, a marine tetrahydroisoquinoline alkaloid, in human non-small cell lung cancer cells

Liu, K.; Wang, J-Li.; Zhao, L.; Wang, Q., 2015:
Anticancer and antimicrobial activities and chemical composition of the birch mazegill mushroom Lenzites betulina (higher Basidiomycetes)

Tamokou, J.de.Dieu.; Chouna, J.Rodolphe.; Fischer-Fodor, E.; Chereches, G.; Barbos, O.; Damian, G.; Benedec, D.; Duma, M.; Efouet, A.Pépin.Nkeng.; Wabo, H.Kamdem.; Kuiate, J.Roger.; Mot, A.; Silaghi-Dumitrescu, R., 2013:
Anticancer and antimicrobial activities of some antioxidant-rich cameroonian medicinal plants

Bhimba, B.Valentin.; Agnel Defora Franco, D.A.; Mathew, J.Merin.; Jose, G.Mary.; Joel, E.Lycias.; Thangaraj, M., 2013:
Anticancer and antimicrobial activity of mangrove derived fungi Hypocrea lixii VB1

Tagne, R.Simo.; Telefo, B.Phelix.; Nyemb, J.Noel.; Yemele, D.Mefokou.; Njina, S.Nguedia.; Goka, Séphanie.Marie.Chekem.; Lienou, L.Lienou.; Nwabo Kamdje, A.Hervé.; Moundipa, P.Fewou.; Farooq, A.Dar., 2014:
Anticancer and antioxidant activities of methanol extracts and fractions of some Cameroonian medicinal plants

Gawlik-Dziki, U.; Świeca, Mł.; Dziki, D.; Sęczyk, Łukasz.; Złotek, U.; Różyło, R.; Kaszuba, K.; Ryszawy, D.; Czyż, Jław., 2015:
Anticancer and antioxidant activity of bread enriched with broccoli sprouts

Aydin, E.; Türkez, H.; Taşdemir, S., 2015:
Anticancer and antioxidant properties of terpinolene in rat brain cells

Malíková, J.; Swaczynová, J.; Kolár, Z.; Strnad, M., 2007:
Anticancer and antiproliferative activity of natural brassinosteroids

Adebayo, A.H.; Tan, N.H.; Akindahunsi, A.A.; Zeng, G.Z.; Zhang, Y.M., 2010:
Anticancer and antiradical scavenging activity of Ageratum conyzoides L. (Asteraceae)

Zorofchian Moghadamtousi, S.; Karimian, H.; Khanabdali, R.; Razavi, M.; Firoozinia, M.; Zandi, K.; Abdul Kadir, H., 2014:
Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae

Kaur, M.; Agarwal, C.; Agarwal, R., 2009:
Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products

Fedorov, S.N.; Ermakova, S.P.; Zvyagintseva, T.N.; Stonik, V.A., 2014:
Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects

López-Lázaro, M., 2008:
Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent

Karikas, G.A., 2011:
Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects

Gerlach, S.L.; Rathinakumar, R.; Chakravarty, G.; Göransson, U.; Wimley, W.C.; Darwin, S.P.; Mondal, D., 2011:
Anticancer and chemosensitizing abilities of cycloviolacin 02 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa

Verginadis, I.I.; Karkabounas, S.; Simos, Y.; Kontargiris, E.; Hadjikakou, S.K.; Batistatou, A.; Evangelou, A.; Charalabopoulos, K., 2011:
Anticancer and cytotoxic effects of a triorganotin compound with 2-mercapto-nicotinic acid in malignant cell lines and tumor bearing Wistar rats

Kumar, V.; Madaan, A.; Sanna, V.K.; Vishnoi, M.; Joshi, N.; Singh, A.T.; Jaggi, M.; Sharma, P.K.; Irchhaiya, R.; Burman, A.C., 2010:
Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives

Liu, J.; Zhang, L.; Ren, Y.; Gao, Y.; Kang, L.; Qiao, Q., 2015:
Anticancer and immunoregulatory activity of Gynostemma pentaphyllum polysaccharides in H22 tumor-bearing mice

Chattopadhyay, S.; Dash, S.Kumar.; Ghosh, T.; Das, S.; Tripathy, S.; Mandal, D.; Das, D.; Pramanik, P.; Roy, S., 2014:
Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles

Zupkó, Ián.; Molnár, J.; Réthy, Bála.; Minorics, Ráta.; Frank, E.; Wölfling, János.; Molnár, J.; Ocsovszki, I.; Topcu, Z.; Bitó, Tás.; Puskás, László.G., 2014:
Anticancer and multidrug resistance-reversal effects of solanidine analogs synthetized from pregnadienolone acetate

Ghorab, M.M.; Ragab, F.A.; Heiba, H.I.; El-Hazek, R.M., 2012:
Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety

Ghorab, M.M.; Shaaban, M.A.; Refaat, H.M.; Heiba, H.I.; Ibrahim, S.S., 2012:
Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety

Troeira Henriques, Sónia.; Huang, Y-Hua.; Chaousis, S.; Wang, C.K.; Craik, D.J., 2015:
Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting

Matés, J.M.; Segura, J.A.; Alonso, F.J.; Márquez, J., 2011:
Anticancer antioxidant regulatory functions of phytochemicals

Harlev, E.; Nevo, E.; Lansky, E.P.; Lansky, S.; Bishayee, A., 2013 :
Anticancer attributes of desert plants: a review

Chang, C-H.; Fu, Y-C.; Li, J-R.; Shu, K-H.; Ho, H-C.; Shiu, Y-N.; Wu, M-J., 2015:
Anticancer benefits of early versus late use of rapamycin in a rat model of urothelial carcinoma

Su, L-Ya.; Xin, H-Yi.; Liu, Y-Lei.; Zhang, J-Ling.; Xin, H-Wu.; Su, X-Lan., 2015:
Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A)

Su, L.; Xu, G.; Shen, J.; Tuo, Y.; Zhang, X.; Jia, S.; Chen, Z.; Su, X., 2010:
Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle

Yu, L.; Yang, L.; An, W.; Su, X., 2014:
Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells

Teiten, M-Hélène.; Gaascht, Fçois.; Dicato, M.; Diederich, M., 2013:
Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions

Paul, R.; Prasad, M.; Sah, N.K., 2012:
Anticancer biology of Azadirachta indica L (neem): a mini review

Monti, S.Maria.; Supuran, C.T.; De Simone, G., 2013:
Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013)

He, W.; Jiang, Y.; Zhang, X.; Zhang, Y.; Ji, H.; Zhang, N., 2014:
Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells

Kratz, F.; Abu Ajaj, K.; Warnecke, Aé., 2007:
Anticancer carrier-linked prodrugs in clinical trials

Debrix, I.; Avenin, Dèle.; André, T.; Abbas, F.; Gligorov, J.; Milleron, B.; Lotz, J-Pierre.; Becker, A., 2009:
Anticancer chemotherapy in the elderly: a review of the literature

Kohga, K.; Takehara, T.; Tatsumi, T.; Miyagi, T.; Ishida, H.; Ohkawa, K.; Kanto, T.; Hiramatsu, N.; Hayashi, N., 2009:
Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma

Jensen, M.; Nerdal, W., 2008:
Anticancer cisplatin interactions with bilayers of total lipid extract from pig brain: A13C, 31P and 15N solid-state NMR study

Zhang, Y.; Wang, J., 2012:
Anticancer clinical utility of the apurinic/apyrimidinic endonuclease/redox factor-1 (APE/Ref-1)

Jamal, M.S.; Parveen, S.; Beg, M.A.; Suhail, M.; Chaudhary, A.G.A.; Damanhouri, G.A.; Abuzenadah, A.M.; Rehan, M., 2014:
Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approaches

Fuertes, M.A.; Nguewa, P.A.; Castilla, J.; Alonso, C.; Pérez, Jé.M., 2008:
Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives

Kharwar, R.N.; Mishra, A.; Gond, S.K.; Stierle, A.; Stierle, D., 2011:
Anticancer compounds derived from fungal endophytes: their importance and future challenges

Kim, S-Kwon.; Thomas, N.Vinay.; Li, X., 2012:
Anticancer compounds from marine macroalgae and their application as medicinal foods

Vortherms, A.R.; Dang, H.N.; Doyle, R.P., 2009:
Anticancer conjugates and cocktails based on methotrexate and nucleoside synergism

Intisar, A.; Zhang, L.; Luo, H.; Kiazolu, J.Boima.; Zhang, R.; Zhang, W., 2014:
Anticancer constituents and cytotoxic activity of methanol-water extract of Polygonum bistorta L

Arouri, A.; Mouritsen, O.G., 2012:
Anticancer double lipid prodrugs: liposomal preparation and characterization

Chen, Y-Yin.; Yeh, C-Hua.; So, E.Cheung.; Sun, D-Ping.; Wang, L-Yun.; Hsing, C-Hsi., 2015:
Anticancer drug 2-methoxyestradiol protects against renal ischemia/reperfusion injury by reducing inflammatory cytokines expression

Kumar, S.; Aninat, C.; Michaux, Gégoire.; Morel, F., 2010:
Anticancer drug 5-fluorouracil induces reproductive and developmental defects in Caenorhabditis elegans

Li, F., 2014:
Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?

Despas, F.; Roche, H.; Laurent, G., 2013:
Anticancer drug adherence

Dickens, H.; Ullrich, A.; Runge, D.; Mueller, B.; Olszewski, U.; Hamilton, G., 2008:
Anticancer drug cis-4-hydroxy-L-proline: Correlation of preclinical toxicology with clinical parameters of liver function

Hino, M.; Matsuda, K.; Miyanaga, A.; Kuribayasi, H.; Mizutani, H.; Noro, R.; Minegishi, Y.; Okano, T.; Seike, M.; Kawakami, A.; Yoshimura, A.; Ogawa, N.; Uesaka, H.; Kudoh, S.; Gemma, A., 2010:
Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel

Svenskaya, Y.; Parakhonskiy, B.; Haase, A.; Atkin, V.; Lukyanets, E.; Gorin, D.; Antolini, R., 2014:
Anticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizer

Hill, R., 2014:
Anticancer drug demonstrates histone eviction activity

Kawabata-Shoda, E.; Masuda, S.; Kimura, H., 2013:
Anticancer drug development from traditional cytotoxic to targeted therapies: evidence of shorter drug research and development time, and shorter drug lag in Japan

Haney, S.A., 2006:
Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation

Ades, F.; Zardavas, D.; Aftimos, P.; Awada, A., 2014:
Anticancer drug development: moving away from the old habits

Colotta, F., 2008:
Anticancer drug discovery and development

Nastrucci, C.; Cesario, A.; Russo, P., 2012:
Anticancer drug discovery from the marine environment

Ma, X.; Wang, Z., 2010:
Anticancer drug discovery in the future: an evolutionary perspective

Yu, N.; Wang, M., 2008:
Anticancer drug discovery targeting DNA hypermethylation

Pétain, Aélie.; Chatelut, E., 2008:
Anticancer drug dose individualisation: from body surface area to physiology

Lehne, G.; Bjørheim, J.; Saeter, G., 2007:
Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?

Nakamura, Y.; Ishida, Y.; Yamada, T.; Shimada, S., 2012:
Anticancer drug irinotecan inhibits homomeric 5-HT3A and heteromeric 5-HT3AB receptor responses

Sittl, R.; Lampert, A.; Huth, T.; Schuy, E.Theresa.; Link, A.S.; Fleckenstein, J.; Alzheimer, C.; Grafe, P.; Carr, R.W., 2012:
Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current

Lin, Q.; Huang, Q.; Li, C.; Bao, C.; Liu, Z.; Li, F.; Zhu, L., 2010:
Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process

Suzuki, M.; Ishikawa, H.; Tanaka, A.; Mataga, I., 2011:
Anticancer drug sensitivity testing using an oxygen electrode apparatus

Lichtman, S.M.; Boparai, M.K., 2008:
Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy

Lau, D.T.; Jarzebowski, M.H.; McKoy, J.M., 2012:
Anticancer drug use in geriatric patients: concerns and challenges

Yuan, J.; Guo, W.; Yang, X.; Wang, E., 2009:
Anticancer drug-DNA interactions measured using a photoinduced electron-transfer mechanism based on luminescent quantum dots

Kim, T-Hyun.; Lee, G.Jin.; Kang, J-Hee.; Kim, H-Jun.; Kim, T-Il.; Oh, J-Min., 2015:
Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment

Kim, J.Young.; Choi, S-Jin.; Oh, J-Min.; Park, T.; Choy, J-Ho., 2007:
Anticancer drug-inorganic nanohybrid and its cellular interaction

Gulfam, M.; Kim, J-eun.; Lee, J.Min.; Ku, B.; Chung, B.Hyun.; Chung, B.Geun., 2012:
Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells

Long, J-Ting.; Cheang, T-Yun.; Zhuo, S-Yu.; Zeng, R-Fang.; Dai, Q-Sheng.; Li, H-Ping.; Fang, S., 2015:
Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis

Yan, G-Ping.; Zong, R-Feng.; Li, L.; Fu, T.; Liu, F.; Yu, X-Hua., 2011:
Anticancer drug-loaded nanospheres based on biodegradable amphiphilic ε-caprolactone and carbonate copolymers

Shkreta, L.; Froehlich, U.; Paquet, E.R.; Toutant, J.; Elela, S.Abou.; Chabot, B., 2008:
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes

Tan, S.; de Vries, E.G.E.; van der Zee, A.G.J.; de Jong, S., 2012:
Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer

Raschi, E.; Vasina, V.; Ursino, M.Grazia.; Boriani, G.; Martoni, A.; De Ponti, F., 2010:
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy

Minisini, A.M.; Pauletto, G.; Andreetta, C.; Bergonzi, P.; Fasola, G., 2008:
Anticancer drugs and central nervous system: clinical issues for patients and physicians

Yuan, F.; Zhou, W.; Zhang, J.; Zhang, Z.; Zou, C.; Huang, L.; Zhang, Y.; Dai, Z., 2008:
Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells

Lv, L-Hong.; Wan, Y-Le.; Lin, Y.; Zhang, W.; Yang, M.; Li, G-Lin.; Lin, H-Ming.; Shang, C-Zhen.; Chen, Y-Jin.; Min, J., 2012:
Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro

Anonymous, 2013:
Anticancer drugs deliver themselves to cancer cells

Ichikawa, H.; Nakamura, Y.; Kashiwada, Y.; Aggarwal, B.B., 2007:
Anticancer drugs designed by mother nature: ancient drugs but modern targets

Chakraborty, C.; Hsu, C-Hsin.; Wen, Z-Hong.; Lin, C-Shing., 2010:
Anticancer drugs discovery and development from marine organism

Pédeboscq, Séphane.; L'Azou, Béatrice.; Passagne, I.; De Giorgi, F.; Ichas, Fçois.; Liguoro, D.; Pometan, J-Paul.; Cambar, J., 2010:
Anticancer drugs exert differential apoptotic and cytotoxic effects on glioblastoma primary cultures with various EGFR and bcl-2 profiles

Sithranga Boopathy, N.; Kathiresan, K., 2010:
Anticancer drugs from marine flora: an overview

Altmann, K-Heinz.; Gertsch, Jürg., 2007:
Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents

Urbinati, G.; Marsaud, V.; Renoir, J-Michel., 2013:
Anticancer drugs in liposomal nanodevices: a target delivery for a targeted therapy

Besse, J-Philippe.; Latour, J-François.; Garric, J., 2012:
Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?

Zimmer-Rapuch, S.; Lheureux, Séphanie.; Brocard, F.; Janus, N.; Launay-Vacher, V.; Ray-Coquard, I., 2012:
Anticancer drugs management in renal insufficiency patients

Rohlena, J.; Dong, L-Feng.; Ralph, S.J.; Neuzil, J., 2012:
Anticancer drugs targeting the mitochondrial electron transport chain

Papandreou, I.; Goliasova, T.; Denko, N.C., 2011:
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?

Ben Aïssa, A.; George, A-C.; El M'Rabet, F.Z.; Mach, N.; Dietrich, P-Y.; Pechère-Bertschi, A., 2011:
Anticancer drugs under pressure

Malinowska, K.; Modranka, R.; Kedziora, Józef., 2007:
Anticancer drugs used in medicine and being in clinical research

Zheng, S-Ying.; Li, Y.; Jiang, D.; Zhao, J.; Ge, J-Feng., 2012:
Anticancer effect and apoptosis induction by quercetin in the human lung cancer cell line A-549

Wang, L.; Dong, J.; Ouyang, W.; Wang, X.; Tang, J., 2012:
Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles

Gao, X.; Wang, B.; Wei, X.; Men, K.; Zheng, F.; Zhou, Y.; Zheng, Y.; Gou, M.; Huang, M.; Guo, G.; Huang, N.; Qian, Z.; Wei, Y., 2013:
Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer

Liu, Z-Jia.; Lv, H-Ning.; Li, H-Yan.; Zhang, Y.; Zhang, H-Jing.; Su, F-Qin.; Si, Y-Kang.; Yu, S-Shan.; Chen, X-Guang., 2011:
Anticancer effect and neurotoxicity of S-(+)-deoxytylophorinidine, a new phenanthroindolizidine alkaloid that interacts with nucleic acids

Tao, L-yang.; Zhang, J-ye.; Liang, Y-ju.; Chen, L-ming.; Zhen, L-sheng.; Wang, F.; Mi, Y-jun.; She, Z-gang.; To, K.Kin.Wah.; Lin, Y-cheng.; Fu, L-wu., 2010:
Anticancer effect and structure-activity analysis of marine products isolated from metabolites of mangrove fungi in the South China Sea

Chae, Y.Soo.; Kim, J.Gwang.; Jung, H.Jun.; Yang, J.Dug.; Jung, J.Hyang.; Aiyar, S.E.; Kim, S.; Park, H., 2011:
Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization

Li, L.; Liu, H.; Zhang, S-Hua.; Hu, L.; Zhen, Y-Su., 2016:
Anticancer effect of 17-(6-cinnamamido-hexylamino-)-17-demethoxygeldanamycin: in vitro and in vivo

Dai, Z-kai.; Yang, X-sheng.; Yu, L-mei., 2013:
Anticancer effect of 5-fluorouracil combined with extract of Rosa roxburghii Tratt on human endometrial adenocarcinoma

Bednarczyk-Cwynar, B.; Zaprutko, L.; Ruszkowski, P.; Hładoń, Bław., 2012:
Anticancer effect of A-ring or/and C-ring modified oleanolic acid derivatives on KB, MCF-7 and HeLa cell lines

Dai, Z-kai.; Yu, L-mei.; Yang, X-sheng., 2007:
Anticancer effect of CL extract of Rosa roxburghii

Altun, A.; Turgut, N.Hacer.; Kaya, T.Temiz., 2015:
Anticancer effect of COX-2 inhibitor DuP-697 alone and in combination with tyrosine kinase inhibitor (E7080) on colon cancer cell lines

Mao, F.; Xiao, B.; Jiang, Z.; Zhao, J.; Huang, X.; Guo, J., 2011:
Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest

Zheng, A.; Li, H.; Wang, X.; Feng, Z.; Xu, J.; Cao, K.; Zhou, B.; Wu, J.; Liu, J., 2015:
Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction

Prasanna, R.; Harish, C.C., 2010:
Anticancer effect of a novel 2-arylidene-4,7-dimethyl indan-1-one against human breast adenocarcinoma cell line by G2/M cell cycle arrest

Daniele, G.; Giordano, P.; De Luca, A.; Piccirillo, M.Carmela.; Di Maio, M.; Del Giudice, A.; De Feo, G.; Bryce, J.; Lamura, L.; Vecchione, A.; Normanno, N.; Perrone, F., 2011:
Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence

Pillai, K.; Ehteda, A.; Akhter, J.; Chua, T.C.; Morris, D.L., 2014:
Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells

Esmaeili, M.Ali.; Farimani, M.Moridi.; Kiaei, M., 2015:
Anticancer effect of calycopterin via PI3K/Akt and MAPK signaling pathways, ROS-mediated pathway and mitochondrial dysfunction in hepatoblastoma cancer (HepG2) cells

Liu, H.; Huang, P.; Xu, X.; Liu, J.; Guo, C., 2008:
Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells

Aung, W.; Sogawa, C.; Furukawa, T.; Saga, T., 2011:
Anticancer effect of dihydroartemisinin (DHA) in a pancreatic tumor model evaluated by conventional methods and optical imaging

Oh, B.; Kim, J.; Lu, W.; Rosenthal, D., 2014:
Anticancer effect of fucoidan in combination with tyrosine kinase inhibitor lapatinib

Hwang, K-A.; Park, M-Ah.; Kang, N-Hee.; Yi, B-Rim.; Hyun, S-Hwan.; Jeung, E-Bae.; Choi, K-Chul., 2013:
Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways

Zheng, Q.; Liu, W-Wei.; Li, B.; Chen, H-Jie.; Zhu, W-Shan.; Yang, G-Xiao.; Chen, M-Jie.; He, G-Yuan., 2014:
Anticancer effect of icaritin on human lung cancer cells through inducing S phase cell cycle arrest and apoptosis

Moon, Y-Hee.; Park, J-Hwan.; Kim, S-A.; Lee, J-Bum.; Ahn, S-Gun.; Yoon, J-Hoon., 2010:
Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma

Zhao, Q-Hong.; Zhang, Y.; Liu, Y.; Wang, H-Li.; Shen, Y-Yuan.; Yang, W-Jun.; Wen, L-Ping., 2011:
Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery

Wang, J.; Li, J-Zhe.; Lu, A-Xia.; Zhang, K-Fen.; Li, B-Jiang., 2014:
Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression

Kil, W.Ho.; Kim, S.Min.; Lee, J.Eon.; Park, K.Sik.; Nam, S.Jin., 2014:
Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells

Guo, J.; Zhang, Y.; Zhang, J.; Liang, J.; Zeng, L.; Guo, G., 2012:
Anticancer effect of tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell line

Machana, S.; Weerapreeyakul, N.; Barusrux, S., 2013:
Anticancer effect of the extracts from Polyalthia evecta against human hepatoma cell line (HepG2)

Yang, R-mei.; Li, W-min.; Hu, W-jun.; Huang, W-hua.; Zhu, C-yan.; Yu, J-guang.; Zhao, X.; Cai, D-yong.; Gao, N-nan., 2016:
Anticancer effect of total annonaceous acetogenins on hepatocarcinoma

Hu, T-nan.; Wang, Q-wen.; Jin, X.; Hu, Q-da.; Wang, X-shi.; Xu, S.; Zhou, J.; Tang, G-ping., 2013:
Anticancer effect of triptolide-polyethylenimine-cyclodextrin in vitro

Wang, J.; Peng, C-An., 2012:
Anticancer effectiveness of polymeric drug nanocarriers on colorectal cancer cells

de Jong, E.; Winkel, P.; Poelstra, K.; Prakash, J., 2012:
Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC

Xu, Y.; Zhang, J.; Shi, W.; Liu, Y., 2013:
Anticancer effects of 3,3'-diindolylmethane are associated with G1 arrest and mitochondria-dependent apoptosis in human nasopharyngeal carcinoma cells

Jiang, J.; Cao, D-Hui.; Tsukamoto, T.; Wang, G-Qing.; Jia, Z-Fang.; Suo, J.; Cao, X-Yuan., 2013:
Anticancer effects of 4-vinyl-2,6-dimethoxyphenol (canolol) against SGC-7901 human gastric carcinoma cells

Zhong, Y-Jun.; Liu, S-Ping.; Firestone, R.A.; Hong, Y-Ping.; Li, Y., 2014:
Anticancer effects of Ac‑Phe‑Lys‑PABC‑doxorubicin via mitochondria‑centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC‑803 cells

Hsu, C-Lin.; Yu, Y-Shan.; Yen, G-Chin., 2010:
Anticancer effects of Alpinia pricei Hayata roots

Ahmadi, A.; Mohagheghi, M.; Karimi, M.; Seyed Ali Golestanha; Naseri, M., 2009:
Anticancer effects of HESA-A in patients with metastatic colon cancer

Ahmadi, A.; Habibi, G.; Farrokhnia, M., 2010:
Anticancer effects of HESA-A: an herbal marine compound

Xu, X.; Wei, Q.; Wang, K.; Ling, Q.; Xie, H.; Zhou, L.; Zheng, S., 2012:
Anticancer effects of Huaier are associated with down-regulation of P53

Hong, S-Won.; Jung, K.Hee.; Choi, M-Joo.; Kim, D.Young.; Lee, H-Seung.; Zheng, H-Mei.; Li, G.Yong.; El-Deeb, I.M.; Park, B.Sun.; Lee, S.Ha.; Hong, S-Sun., 2013:
Anticancer effects of KI-10F: a novel compound affecting apoptosis, angiogenesis and cell growth in colon cancer

Xie, X.; Tian, Y.; Yin, S.; Lin, Y.; Tan, G., 2014:
Anticancer effects of Ligusticum chuanxiong Hort alcohol extracts on HS766T cell

Choi, E.Jeong.; Lee, J-In.; Kim, G-Hee., 2013:
Anticancer effects of O-desmethylangolensin are mediated through cell cycle arrest at the G2/M phase and mitochondrial-dependent apoptosis in Hep3B human hepatocellular carcinoma cells

Sun, M-Lei.; Wang, C-Mei.; Wen, Y-Ming., 2015:
Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro

Wang, M-qun.; Liu, Y-nan.; Zhao, X.; Zhang, Y., 2011:
Anticancer effects of a novel indolinone compound in nasopharyngeal carcinoma cells

Roomi, M.W.; Kalinovsky, T.; Roomi, N.W.; Rath, M.; Niedzwiecki, A., 2012:
Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines

Nakajima, K.; Yokoyama, A.; Nakajima, Y., 2010:
Anticancer effects of a tertiary sulfonium compound, dimethylsulfoniopropionate, in green sea algae on Ehrlich ascites carcinoma-bearing mice

Raykov, Z.; Georgieva, P.B.; Angelova, A.; Galabov, A.S.; Rommelaere, J., 2009:
Anticancer effects of an oncolytic parvovirus combined with non-conventional therapeutics on pancreatic carcinoma cell lines

Park, S-Woo.; Kim, J-Eun.; Oh, S-Mi.; Cha, W-Jae.; Hah, J-Hun.; Sung, M-Whun., 2016:
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species

Zheng, Y-Hu.; Yin, L-Hui.; Grahn, T.Hooi.Min.; Ye, A-Fang.; Zhao, Y-Rong.; Zhang, Q-Yu., 2014:
Anticancer effects of baicalein on hepatocellular carcinoma cells

Serasanambati, M.; Chilakapati, S.Reddy.; Manikonda, P.Kumar.; Kanala, J.Reddy.; Chilakapati, D.Reddy., 2015:
Anticancer effects of brucine and gemcitabine combination in MCF-7 human breast cancer cells

Miao, Q.; Bi, L-Lin.; Li, X.; Miao, S.; Zhang, J.; Zhang, S.; Yang, Q.; Xie, Y-Hua.; Zhang, J.; Wang, S-Wang., 2013:
Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy

Liu, D-Bo.; Long, G-Xian.; Mei, Q.; Wang, J-Feng.; Hu, G-Yuan.; Gan, L.; Li, W-Wen.; Sun, W.; Liu, S-Fang.; Jiang, J-Zong.; Hu, G-Qing., 2014:
Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines

Liu, W.; Wang, Y.; Wang, H.; Wang, A., 2015:
Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer

Karagozlu, M.Zafer.; Kim, S-Kwon., 2014:
Anticancer effects of chitin and chitosan derivatives

Huang, Y.; Zeng, F.; Xu, L.; Zhou, J.; Liu, X.; Le, H., 2014:
Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells

Bathaie, S.Zahra.; Hoshyar, R.; Miri, H.; Sadeghizadeh, M., 2014:
Anticancer effects of crocetin in both human adenocarcinoma gastric cancer cells and rat model of gastric cancer

Xiang, J.; Xiang, Y.; Lin, S.; Xin, D.; Liu, X.; Weng, L.; Chen, T.; Zhang, M., 2014:
Anticancer effects of deproteinized asparagus polysaccharide on hepatocellular carcinoma in vitro and in vivo

Moussavou, G.; Kwak, D.Hoon.; Obiang-Obonou, B.Wilfried.; Maranguy, C.Abel.Ogandaga.; Dinzouna-Boutamba, S-Danne.; Lee, D.Hoon.; Pissibanganga, O.Gwenaelle.Manvoudou.; Ko, K.; Seo, J.In.; Choo, Y.Kug., 2015:
Anticancer effects of different seaweeds on human colon and breast cancers

Lee, Y-Pang.; Tsai, W-Chi.; Ko, C-Jan.; Rao, Y.Koteswara.; Yang, C-Ru.; Chen, D-Ren.; Yang, M-Hui.; Yang, C-Chiang.; Tzeng, Y-Min., 2012:
Anticancer effects of eleven triterpenoids derived from Antrodia camphorata

Lemieszek, M.Kinga.; Langner, E.; Kaczor, Józef.; Kandefer-Szerszeń, M.; Sanecka, B.; Mazurkiewicz, W.; Rzeski, W., 2012:
Anticancer effects of fraction isolated from fruiting bodies of Chaga medicinal mushroom, Inonotus obliquus (Pers.:Fr.) Pilát (Aphyllophoromycetideae): in vitro studies

Senthilkumar, K.; Kim, S-Kwon., 2014:
Anticancer effects of fucoidan

Liao, F.; Saitoh, Y.; Miwa, N., 2011:
Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts

Tsubura, A.; Lai, Y-Chang.; Kuwata, M.; Uehara, N.; Yoshizawa, K., 2011:
Anticancer effects of garlic and garlic-derived compounds for breast cancer control

Niknejad, H.; Yazdanpanah, G., 2014:
Anticancer effects of human amniotic membrane and its epithelial cells

Luo, K-wang.; Sun, J-guo.; Chan, J.Yuet-Wa.; Yang, L.; Wu, S-hua.; Fung, K-Pui.; Liu, F-yan., 2012:
Anticancer effects of imperatorin isolated from Angelica dahurica: induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways

Zhang, Y.; Lima, C.F.; Rodrigues, L.R., 2015:
Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy

Rokkaku, T.; Kimura, R.; Ishikawa, C.; Yasumoto, T.; Senba, M.; Kanaya, F.; Mori, N., 2014:
Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma

Guppy, A.; Jamal-Hanjani, M.; Pickering, L., 2011:
Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer

Vlotides, G.; Tanyeri, A.; Spampatti, M.; Zitzmann, K.; Chourdakis, M.; Spttl, C.; Maurer, J.; Nölting, S.; Göke, B.; Auernhammer, C.J., 2015:
Anticancer effects of metformin on neuroendocrine tumor cells in vitro

Wieland, A.; Trageser, D.; Gogolok, S.; Reinartz, R.; Höfer, H.; Keller, M.; Leinhaas, A.; Schelle, R.; Normann, S.; Klaas, L.; Waha, A.; Koch, P.; Fimmers, R.; Pietsch, T.; Yachnis, A.T.; Pincus, D.W.; Steindler, D.A.; Brüstle, O.; Simon, M.; Glas, M.; Scheffler, Börn., 2014:
Anticancer effects of niclosamide in human glioblastoma

Tanaka, M.; Kataoka, H.; Mabuchi, M.; Sakuma, S.; Takahashi, S.; Tujii, R.; Akashi, H.; Ohi, H.; Yano, S.; Morita, A.; Joh, T., 2011:
Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer

Miyano-Kurosaki, N.; Ikegami, K.; Kurosaki, K.; Endo, T.; Aoyagi, H.; Hanami, M.; Yasumoto, J.; Tomoda, A., 2009:
Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells

Zhao, J.; Wu, Y.; Alfred, A.T.; Wei, P.; Yang, S., 2014:
Anticancer effects of pyocyanin on HepG2 human hepatoma cells

Ohgidani, M.; Ichihara, H.; Goto, K.; Matsumoto, Y.; Ueoka, R., 2012:
Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo

Wang, H-Gang.; Huang, X-Dan.; Shen, P.; Li, L-Rong.; Xue, H-Ting.; Ji, G-Zhong., 2014:
Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro

Tzao, C.; Jin, J-S.; Chen, B-H.; Chung, H-Y.; Chang, C-C.; Hsu, T-Y.; Sun, G-H., 2015:
Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo

Li, P-Gao.; Mu, T-Hua.; Deng, L., 2014:
Anticancer effects of sweet potato protein on human colorectal cancer cells

Ferreira, A.Kleber.; Meneguelo, R.; Pereira, A.; Mendonça Filho, O..R.; Chierice, G.Orivaldo.; Maria, D.Augusto., 2012:
Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study

Lee, C-Yu.; Sher, H-Fang.; Chen, H-Wen.; Liu, C-Chi.; Chen, C-Hsien.; Lin, C-Sea.; Yang, P-Chyr.; Tsay, H-Sheng.; Chen, J.J.W., 2008:
Anticancer effects of tanshinone I in human non-small cell lung cancer

Zhao, Q.; Wu, C-Zhu.; Lee, J.Kyoung.; Zhao, S-Rong.; Li, H-Mei.; Huo, Q.; Ma, T.; Zhang, J.; Hong, Y-Soo.; Liu, H., 2015:
Anticancer effects of the Hsp90 inhibitor 17-demethoxy-reblastatin in human breast cancer MDA-MB-231 cells

Jeon, H.Sook.; Ahn, M.Young.; Park, J.Hye.; Kim, T.Hyung.; Chun, P.; Kim, W.Hee.; Kim, J.; Moon, H.Ryong.; Jung, J.H.; Kim, H.Sik., 2010:
Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells

Kim, H-Sun.; Yi, B-Rim.; Hwang, K-A.; Kim, S.U.; Choi, K-Chul., 2014:
Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward HeLa cervical cancer cells

Androutsopoulos, V.P.; Mahale, S.; Arroo, R.R.J.; Potter, G., 2009 :
Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation

Androutsopoulos, V.P.; Ruparelia, K.C.; Papakyriakou, A.; Filippakis, H.; Tsatsakis, A.M.; Spandidos, D.A., 2011:
Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency

Rothweiler, F.; Michaelis, M.; Brauer, P.; Otte, Jürgen.; Weber, K.; Fehse, B.; Doerr, H.Wilhelm.; Wiese, M.; Kreuter, Jörg.; Al-Abed, Y.; Nicoletti, F.; Cinatl, J., 2011:
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells

Olszewski, U.; Zeillinger, R.; Kars, M.Demirel.; Zalatnai, A.; Molnar, J.; Hamilton, G., 2013:
Anticancer effects of the organosilicon multidrug resistance modulator SILA 421

Sonnemann, Jürgen.; Palani, C.D.; Wittig, S.; Becker, S.; Eichhorn, F.; Voigt, A.; Beck, J.F., 2011:
Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cells

Ulasli, S.Sarinc.; Celik, S.; Gunay, E.; Ozdemir, M.; Hazman, O.; Ozyurek, A.; Koyuncu, T.; Unlu, M., 2014:
Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene

Liu, J-Song.; He, S-Cai.; Zhang, Z-Liang.; Chen, R.; Fan, L.; Qiu, G-Lin.; Chang, S.; Li, L.; Che, X-Ming., 2015:
Anticancer effects of β-elemene in gastric cancer cells and its potential underlying proteins: a proteomic study

Yim, E-Kyoung.; Tong, S-Yun.; Ho, E-Mi.; Bae, J-Hoon.; Um, S-Jong.; Park, J-Sup., 2009:
Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells

Lee, C-I.; Wu, C-Chung.; Hsieh, S-Ling.; Lee, C-Lin.; Chang, Y-Ping.; Chang, C-Chuan.; Wang, Y-Zhen.; Wang, J-Jye., 2015:
Anticancer effects on human pancreatic cancer cells of triterpenoids, polysaccharides and 1,3-β-D-glucan derived from the fruiting body of Antrodia camphorata

Avdikos, A.; Karkabounas, S.; Metsios, A.; Kostoula, O.; Havelas, K.; Binolis, J.; Verginadis, I.; Hatziaivazis, G.; Simos, I.; Evangelou, A., 2007:
Anticancer effects on leiomyosarcoma-bearing Wistar rats after electromagnetic radiation of resonant radiofrequencies

Wang, Y.; Qi, X.; Li, D.; Zhu, T.; Mo, X.; Li, J., 2015:
Anticancer efficacy and absorption, distribution, metabolism, and toxicity studies of aspergiolide A in early drug development

Zheng, X.Ting.; Chen, P.; Li, C.Ming., 2013:
Anticancer efficacy and subcellular site of action investigated by real-time monitoring of cellular responses to localized drug delivery in single cells

Chen, Y.; Wan, Y.; Wang, Y.; Zhang, H.; Jiao, Z., 2012:
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles

Li, M-Yue.; Leung, J.; Kong, A.W.Y.; Liang, N.Ci.; Wu, K.; Hsin, M.K.Y.; Deng, Y.Feng.; Gong, X.; Lv, Y.; Mok, T.S.K.; Underwood, M.J.; Chen, G.G., 2011:
Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells

Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.M.; Zannettino, A.C.W.; Evdokiou, A., 2011:
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

Selvendiran, K.; Tong, L.; Bratasz, A.; Kuppusamy, M.Lakshmi.; Ahmed, S.; Ravi, Y.; Trigg, N.J.; Rivera, B.K.; Kálai, Tás.; Hideg, Kálmán.; Kuppusamy, P., 2010:
Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts

Khan, A.Ali.; Jabeen, M.; Khan, A.Ahmed.; Owais, M., 2014:
Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma

Thamilselvan, V.; Menon, M.; Thamilselvan, S., 2011:
Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway

Gevorkyan, L.; Gambashidze, K., 2015:
Anticancer efficacy of hydroxyethylthiamine diphosphate in vivo

Farazuddin, M.; Sharma, B.; Khan, A.Ahmed.; Joshi, B.; Owais, M., 2012:
Anticancer efficacy of perillyl alcohol-bearing PLGA microparticles

Chang, J-Eun.; Yoon, I-Soo.; Sun, P-Li.; Yi, E.; Jheon, S.; Shim, C-Koo., 2015:
Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer

Kochuparambil, S.T.; Al-Husein, B.; Goc, A.; Soliman, S.; Somanath, P.R., 2011:
Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression

Reddy, L.Harivardhan.; Renoir, J-Michel.; Marsaud, V.; Lepetre-Mouelhi, S.; Desmaële, D.; Couvreur, P., 2009:
Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor

Ganapathy-Kanniappan, S.; Kunjithapatham, R.; Geschwind, J-Francois., 2013:
Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting

Sugitachi, A.; Kimura, Y.; Itabashi, T.; Ikeda, M.; Ishida, K.; Noda, H.; Matsuo, T.; Nishizuka, S.; Otsuka, K.; Koeda, K.; Sato, A.; Takahashi, T.; Wakabayashi, G., 2011:
Anticancer efficacy with cisplatin delivery systems

Rajpoot, P.; Bali, V.; Pathak, K., 2012:
Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan

Figová, K.; Hraběta, J.; Eckschlager, T., 2014:
Anticancer efficiency of reovirus in normoxia and hypoxia

Shamroukh, A.H.; El-Shahat, M.; Drabowicz, Józef.; Ali, M.M.; Rashad, A.E.; Ali, H.S., 2014:
Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative

Costa, L.; Harper, P.; Coleman, R.E.; Lipton, A., 2011:
Anticancer evidence for zoledronic acid across the cancer continuum

Cheng, Y-sheng.; Xu, F., 2011:
Anticancer function of polyinosinic-polycytidylic acid

Pazarentzos, E.; Mazarakis, N.D., 2014:
Anticancer gene transfer for cancer gene therapy

Grimm, S.; Noteborn, M., 2010:
Anticancer genes: inducers of tumour-specific cell death signalling

Tian, S.; Siu, F-Ming.; Kui, S.C.F.; Lok, C-Nam.; Che, C-Ming., 2011:
Anticancer gold(I)-phosphine complexes as potent autophagy-inducing agents

Nepali, K.; Sharma, S.; Kumar, D.; Budhiraja, A.; Dhar, K.L., 2015:
Anticancer hybrids--a patent survey

Paradziej-Łukowicz, J.; Skwarska, A.; Peszyńska-Sularz, Gżyna.; Brillowska-Dąbrowska, A.; Konopa, J., 2012:
Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis

Bernal, S.D.; Ona, E.T.; Riego-Javier, A.; DE Villa, R.; Cristal-Luna, G.R.; Laguatan, J.B.; Batac, E.R.; Canlas, O.Q., 2012:
Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells

Zitvogel, L.; Kroemer, G., 2009:
Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects

Bruserud, Øystein.; Ersvaer, E.; Olsnes, A.; Gjertsen, Børn.Tore., 2009:
Anticancer immunotherapy in combination with proapoptotic therapy

Nisa, S.; Bibi, Y.; Zia, M.; Waheed, A.; Chaudhary, M.Fayyaz., 2013:
Anticancer investigations on Carissa opaca and Toona ciliata extracts against human breast carcinoma cell line

Ionkova, I., 2012:
Anticancer lignans--from discovery to biotechnology

Bao, Y-Yang.; Zhou, S-Hong.; Fan, J.; Wang, Q-Ying., 2014:
Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers

Choi, E.Jeong.; Kim, G-Hee., 2012:
Anticancer mechanism of equol in 7,12-dimethylbenz(a)anthracene-treated animals

Tang, C.; Shao, X.; Sun, B.; Huang, W.; Qiu, F.; Chen, Y.; Shi, Y-kang.; Zhang, E-yong.; Wang, C.; Zhao, X., 2010:
Anticancer mechanism of peptide P18 in human leukemia K562 cells

Ausbacher, D.; Svineng, Gørg.; Hansen, T.; Strøm, M.B., 2012:
Anticancer mechanisms of action of two small amphipathic β(2,2)-amino acid derivatives derived from antimicrobial peptides

Ottewell, P.D.; Woodward, J.K.; Lefley, D.V.; Evans, C.Alyson.; Coleman, R.E.; Holen, I., 2010:
Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone

Dong, Y-Heng.; Guo, Y-Han.; Gu, X-Bin., 2011:
Anticancer mechanisms of vitamin E succinate

Samra, Z.Qadir.; Ahmad, S.; Javeid, M.; Dar, N.; Aslam, M.Shahbaz.; Gull, I.; Ahmad, M.Mustaneer., 2014:
Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron

Ganot, N.; Meker, S.; Reytman, L.; Tzubery, A.; Tshuva, E.Y., 2014:
Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay

Kaluderović, G.N.; Paschke, R., 2012:
Anticancer metallotherapeutics in preclinical development

Barahuie, F.; Hussein, M.Zobir.; Abd Gani, S.; Fakurazi, S.; Zainal, Z., 2015:
Anticancer nanodelivery system with controlled release property based on protocatechuate-zinc layered hydroxide nanohybrid

Taurin, S.; Nehoff, H.; Greish, K., 2013:
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?

Banna, G.Luigi.; Collovà, E.; Gebbia, V.; Lipari, H.; Giuffrida, P.; Cavallaro, S.; Condorelli, R.; Buscarino, C.; Tralongo, P.; Ferraù, F., 2010:
Anticancer oral therapy: emerging related issues

Dara, A.; Sangamwar, A.T., 2015:
Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations

Perera, Y.; Farina, Hán.G.; Gil, J.; Rodriguez, A.; Benavent, F.; Castellanos, L.; Gómez, R.E.; Acevedo, B.E.; Alonso, D.F.; Perea, S.E., 2011:
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

Gross, S.; Andrä, Jörg., 2013:
Anticancer peptide NK-2 targets cell surface sulphated glycans rather than sialic acids

Sarafraz-Yazdi, E.; Bowne, W.B.; Adler, V.; Sookraj, K.A.; Wu, V.; Shteyler, V.; Patel, H.; Oxbury, W.; Brandt-Rauf, P.; Zenilman, M.E.; Michl, J.; Pincus, M.R., 2010:
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes

Gaspar, D.; Veiga, A.Salomé.; Sinthuvanich, C.; Schneider, J.P.; Castanho, M.A.R.B., 2012:
Anticancer peptide SVS-1: efficacy precedes membrane neutralization

Wang, Y.; Li, P.; Wang, S.; Hu, J.; Chen, X.Amy.; Wu, J.; Fisher, M.; Oshaben, K.; Zhao, N.; Gu, Y.; Wang, D.; Chen, G.; Wang, Y., 2012:
Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity

Scherer, K.M.; Bisby, R.H.; Botchway, S.W.; Hadfield, J.A.; Parker, A.W., 2015:
Anticancer phototherapy using activation of E-combretastatins by two-photon-induced isomerization

Dandawate, P.; Ahmad, A.; Deshpande, J.; Swamy, K.Venkateswara.; Khan, E.M.; Khetmalas, M.; Padhye, S.; Sarkar, F., 2015:
Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells

Chin, C.Fei.; Wong, D.Yuan.Qiang.; Jothibasu, R.; Ang, W.Han., 2012:
Anticancer platinum (IV) prodrugs with novel modes of activity

Alemán, Jé.; del Solar, V.; Navarro-Ranninger, C., 2010:
Anticancer platinum complexes as non-innocent compounds for catalysis in aqueous media

Markovsky, E.; Baabur-Cohen, H.; Satchi-Fainaro, R., 2015:
Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs

Zong, A.; Cao, H.; Wang, F., 2013:
Anticancer polysaccharides from natural resources: a review of recent research

Dubey, A.; Min, J.Wook.; Koo, H.Jung.; Kim, H.; Cook, T.R.; Kang, S.Chan.; Stang, P.J.; Chi, K-Whan., 2014:
Anticancer potency and multidrug-resistant studies of self-assembled arene-ruthenium metallarectangles

Yu, T.; Zhang, Y.; He, H.; Zhou, S.; Liu, Y.; Huang, P., 2012:
Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin

Zhao, J.; Gou, S.; Liu, F.; Sun, Y.; Gao, C., 2014:
Anticancer potency of platinum(II) complexes containing both chloride anion and chelated carboxylate as leaving groups

Sivertsen, A.; Tørfoss, V.; Isaksson, J.; Ausbacher, D.; Anderssen, T.; Brandsdal, Børn-Olav.; Havelkova, M.; Skjørholm, A.Elisabeth.; Strøm, M.B., 2014:
Anticancer potency of small linear and cyclic tetrapeptides and pharmacokinetic investigations of peptide binding to human serum albumin

Mishra, A.; Jeong, Y.Joon.; Jo, J-Ho.; Kang, S.Chan.; Lah, M.Soo.; Chi, K-Whan., 2014:
Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls

Ludwig, G.; Ranđelović, I.; Maksimović-Ivanić, D.; Mijatović, S.; Bulatović, M.Z.; Miljković, D.; Korb, M.; Lang, H.; Steinborn, D.; Kaluđerović, G.N., 2016:
Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands

Das, S.; Chatterjee, N.; Bose, D.; Dey, S.Kr.; Munda, R.Narayan.; Nandy, A.; Bera, S.; Biswas, S.Kr.; Das Saha, K., 2012:
Anticancer potential of 3-(arylideneamino)-2-phenylquinazoline-4(3H)-one derivatives

Mondal, J.; Panigrahi, A.Kumar.; Khuda-Bukhsh, A.Rahman., 2014:
Anticancer potential of Conium maculatum extract against cancer cells in vitro: Drug-DNA interaction and its ability to induce apoptosis through ROS generation

Li, G.; Yu, K.; Li, F.; Xu, K.; Li, J.; He, S.; Cao, S.; Tan, G., 2014:
Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers

Kumar, P.S.; Febriyanti, R.M.; Sofyan, F.F.; Luftimas, D.E.; Abdulah, R., 2014:
Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines

Oh, S-Mi.; Kim, J.; Lee, J.; Yi, J-Mu.; Oh, D-Seok.; Bang, O-Sun.; Kim, N.Soo., 2012:
Anticancer potential of an ethanol extract of Asiasari radix against HCT-116 human colon cancer cells in vitro

Byambaragchaa, M.; Dela Cruz, J.; Kh, A.; Hwang, S-Gu., 2015:
Anticancer potential of an ethanol extract of Saussurea involucrata against hepatic cancer cells in vitro

Gomes, A.; Bhattacharjee, P.; Mishra, R.; Biswas, A.K.; Dasgupta, S.Chandra.; Giri, B., 2010:
Anticancer potential of animal venoms and toxins

Fang, S.; Lin, C.; Zhang, Q.; Wang, L.; Lin, P.; Zhang, J.; Wang, X., 2012:
Anticancer potential of aqueous extract of alocasia macrorrhiza against hepatic cancer in vitro and in vivo

Paul, A.; Das, J.; Das, S.; Samadder, A.; Khuda-Bukhsh, A.Rahman., 2014:
Anticancer potential of myricanone, a major bioactive component of Myrica cerifera: novel signaling cascade for accomplishing apoptosis

Saleem, S.; Shaharyar, M.Adil.; Khusroo, M.Jawed.; Ahmad, P.; Rahman, R.Ur.; Ahmad, K.; Alam, M.Jahangir.; Al-Harbi, N.O.; Iqbal, M.; Imam, F., 2014:
Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats

Paul, S.; Bhattacharyya, S.Sundar.; Samaddar, A.; Boujedaini, N.; Khuda-Bukhsh, A.Rahman., 2012:
Anticancer potentials of root extract of Polygala senega against benzo[a]pyrene-induced lung cancer in mice

Wang, Y-Hu.; Morris-Natschke, S.L.; Yang, J.; Niu, H-Mei.; Long, C-Lin.; Lee, K-Hsiung., 2014:
Anticancer principles from medicinal piper ( hú jiāo) plants

Arpicco, S.; Dosio, F.; Stella, B.; Cattel, L., 2012:
Anticancer prodrugs: an overview of major strategies and recent developments

Rubbiani, R.; Zehnder, T.N.; Mari, C.; Blacque, O.; Venkatesan, K.; Gasser, G., 2015:
Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes

Demin, E.V.; Merabishvili, V.M., 2014:
Anticancer propaganda: myth or reality?

Xue, M.; Ge, Y.; Zhang, J.; Wang, Q.; Hou, L.; Liu, Y.; Sun, L.; Li, Q., 2013:
Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo

Ismail, M.; Bagalkotkar, G.; Iqbal, S.; Adamu, H.Altine., 2012:
Anticancer properties and phenolic contents of sequentially prepared extracts from different parts of selected medicinal plants indigenous to Malaysia

Hu, W.; Zhang, C.; Fang, Y.; Lou, C., 2011:
Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo

Mezencev, R.; Kutschy, P.; Salayová, A.; Curillová, Z.; Mojzis, Ján.; Pilátová, M.; McDonald, J., 2008:
Anticancer properties of 2-piperidyl analogues of the natural indole phytoalexin 1-methoxyspirobrassinol

Harhaji Trajković, L.M.; Mijatović, S.A.; Maksimović-Ivanić, D.D.; Stojanović, I.D.; Momcilović, M.B.; Tufegdzić, S.J.; Maksimović, V.M.; Marjanović, Z.S.; Stosić-Grujicić, S.D., 2010:
Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo

Yang, T.; Liu, J.; Luo, F.; Lin, Q.; Rosol, T.J.; Deng, X., 2015:
Anticancer properties of Monascus metabolites

Tafrihi, M.; Toosi, S.; Minaei, T.; Gohari, A.Reza.; Niknam, V.; Arab Najafi, S.Mahmoud., 2014:
Anticancer properties of Teucrium persicum in PC-3 prostate cancer cells

Magedov, I.V.; Frolova, L.; Manpadi, M.; Bhoga, U.devi.; Tang, H.; Evdokimov, N.M.; George, O.; Georgiou, K.Hadje.; Renner, S.; Getlik, Mäus.; Kinnibrugh, T.L.; Fernandes, M.A.; Van slambrouck, S.; Steelant, W.F.A.; Shuster, C.B.; Rogelj, S.; van Otterlo, W.A.L.; Kornienko, A., 2011:
Anticancer properties of an important drug lead podophyllotoxin can be efficiently mimicked by diverse heterocyclic scaffolds accessible via one-step synthesis

Gibot, L.; Chabaud, Séphane.; Bouhout, S.; Bolduc, Séphane.; Auger, Fçois.A.; Moulin, Véronique.J., 2015:
Anticancer properties of chitosan on human melanoma are cell line dependent

Hooft van Huijsduijnen, R.; Guy, R.Kiplin.; Chibale, K.; Haynes, R.K.; Peitz, I.; Kelter, G.; Phillips, M.A.; Vennerstrom, J.L.; Yuthavong, Y.; Wells, T.N.C., 2014:
Anticancer properties of distinct antimalarial drug classes

Hahm, S-Wook.; Park, J.; Oh, S-Yeong.; Lee, C-Won.; Park, K-Young.; Kim, H.; Son, Y-Suk., 2015:
Anticancer properties of extracts from Opuntia humifusa against human cervical carcinoma cells

Clere, N.; Faure, Sébastien.; Martinez, M.Carmen.; Andriantsitohaina, R., 2011:
Anticancer properties of flavonoids: roles in various stages of carcinogenesis

Ahmad, A.; Sakr, W.A.; Rahman, K.M.Wahidur., 2010:
Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy

Bahrami, F.; Morris, D.L.; Rufener, L.; Pourgholami, M.H., 2014:
Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer

Markowicz, S.; Matalinska, J.; Kurzepa, K.; Bochynska, M.; Biernacka, M.; Samluk, A.; Dudek, D.; Skurzak, H.; Yoshikawa, M.; Lipkowski, A.W., 2015:
Anticancer properties of peptide fragments of hair proteins

Lemieszek, M.; Rzeski, W., 2012:
Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class

Youn, S.Hyeon.; Lee, J.Sun.; Lee, M.Sun.; Cha, E.Young.; Thuong, P.Thien.; Kim, J.Ryong.; Chang, E.Sung., 2012:
Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells

Engel, M.A.; Neurath, M.F., 2011:
Anticancer properties of the IL-12 family--focus on colorectal cancer

Chirumbolo, S., 2014:
Anticancer properties of the flavone wogonin

Green, J.; Lipton, A., 2010:
Anticancer properties of zoledronic acid

Pillai, K.; Akhter, J.; Chua, T.C.; Morris, D.Lawson., 2013 :
Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma

Maurya, D.K.; Nandakumar, N.; Devasagayam, T.Paul.Asir., 2011:
Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms

Ravikumar, S.; Fredimoses, M.; Gnanadesigan, M., 2012:
Anticancer property of sediment actinomycetes against MCF-7 and MDA-MB-231 cell lines

Sadafi, F-Zagros.; Massai, L.; Bartolommei, G.; Moncelli, M.Rosa.; Messori, L.; Tadini-Buoninsegni, F., 2015:
Anticancer ruthenium(III) complex KP1019 interferes with ATP-dependent Ca2+ translocation by sarco-endoplasmic reticulum Ca2+-ATPase (SERCA)

Muktapuram, P.Reddy.; Gara, R.Kumar.; Sharma, K.; Rohit, C.; Srinivas, K.; Mishra, D.Prasad.; Bathula, S.Reddy., 2013:
Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killing

Woo, L.W.Lawrence.; Fischer, D.S.; Sharland, C.M.; Trusselle, M.; Foster, P.A.; Chander, S.K.; Di Fiore, A.; Supuran, C.T.; De Simone, G.; Purohit, A.; Reed, M.J.; Potter, B.V.L., 2008:
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography

Salvador, J.A.R.; Carvalho, Jão.F.S.; Neves, M.A.C.; Silvestre, S.M.; Leitão, A.J.; Silva, M.Manuel.C.; Sá e Melo, M.Luisa., 2013:
Anticancer steroids: linking natural and semi-synthetic compounds

Kumar, K.Sathish.; Kumar, P.Senthil.; Vijayalakshmi, S., 2011:
Anticancer studies of drug encapsulated polyethylene terephthalate-Co-polylactic acid nanocapsules

Ivanova, T.S.; Krupodorova, T.A.; Barshteyn, V.Y.; Artamonova, A.B.; Shlyakhovenko, V.A., 2015:
Anticancer substances of mushroom origin

Porporato, P.E.; Dhup, S.; Dadhich, R.K.; Copetti, T.; Sonveaux, P., 2011:
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review

Esposito, L.; Indovina, P.; Magnotti, F.; Conti, D.; Giordano, A., 2014:
Anticancer therapeutic strategies based on CDK inhibitors

Vergara, E.; Casini, A.; Sorrentino, F.; Zava, O.; Cerrada, E.; Rigobello, M.Pia.; Bindoli, A.; Laguna, M.; Dyson, P.J., 2010:
Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands

Broxterman, H.J.; Georgopapadakou, N.H., 2007:
Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma

Bay, J-O.; Larsen, C-J., 2009:
Anticancer therapeutics: should a different therapeutic concept be considered?

Platt, V.M.; Szoka, F.C., 2008:
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor

Chamberlain, M.C., 2010:
Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability

Compton, L.A.; Hiebert, S.W., 2010:
Anticancer therapy SMRT-ens up: targeting the BCL6-SMRT interaction in B cell lymphoma

Yang, T.J.; Haimovitz-Friedman, A.; Verheij, M., 2013:
Anticancer therapy and apoptosis imaging

Schwöppe, C.; Zerbst, C.; Fröhlich, M.; Schliemann, C.; Kessler, T.; Liersch, R.; Overkamp, L.; Holtmeier, R.; Stypmann, Jörg.; Dreiling, A.; König, S.; Höltke, C.; Lücke, M.; Müller-Tidow, C.; Mesters, R.M.; Berdel, W.E., 2013:
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor

Varol, U.; Yildiz, I.; Alacacioglu, A.; Uslu, R., 2014:
Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments

Thiery-Vuillemin, A.; Chaigneau, L.; Meaux-Ruault, N.; Villanueva, C.; N'guyen, T.; Maurina, T.; Stein, U.; Lorgis, Véronique.; Demarchi, M.; Pivot, X., 2008:
Anticancer therapy in patients with porphyrias: evidence today

Geiger, S.; Lange, V.; Suhl, P.; Heinemann, V.; Stemmler, H-Joachim., 2010:
Anticancer therapy induced cardiotoxicity: review of the literature

Parkinson, E.Kenneth.; Minty, F., 2007:
Anticancer therapy targeting telomeres and telomerase : current status

Garrett, M.D.; Collins, I., 2011:
Anticancer therapy with checkpoint inhibitors: what, where and when?

Lacouture, M.E.; Lenihan, D.; Wu, S., 2012:
Anticancer therapy-induced adverse events: practicing damage control

Hendrickson, A.Wahner.; Meng, X.Wei.; Kaufmann, S.H., 2008:
Anticancer therapy: boosting the bang of Bim

Byers, T., 2010:
Anticancer vitamins du Jour--The ABCED's so far

Sinthuvanich, C.; Veiga, A.Salomé.; Gupta, K.; Gaspar, D.; Blumenthal, R.; Schneider, J.P., 2012:
Anticancer β-hairpin peptides: membrane-induced folding triggers activity

Rani, P.; Pal, D.; Hegde, R.Rama.; Hashim, S.Riaz., 2015:
Anticancer, anti-inflammatory, and analgesic activities of synthesized 2-(substituted phenoxy) acetamide derivatives

Ismail, M.A.; Arafa, R.K.; Youssef, M.M.; El-Sayed, W.M., 2015:
Anticancer, antioxidant activities, and DNA affinity of novel monocationic bithiophenes and analogues

Yu, J-Qing.; Lei, J-Chuan.; Zhang, X-Qiao.; Yu, H-Dong.; Tian, D-Zhi.; Liao, Z-Xiong.; Zou, G-Lin., 2011:
Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel

Baliga, M.Shrinath., 2012:
Anticancer, chemopreventive and radioprotective potential of black plum (Eugenia jambolana lam.)

Meinig, J.Matthew.; Peterson, B.R., 2016:
Anticancer/antiviral agent Akt inhibitor-IV massively accumulates in mitochondria and potently disrupts cellular bioenergetics

Hussain, S.Shaik.; Agoumi, A.; Amghar, S.; Boukachabine, K., 2013:
Anticandida activity of the marketed essential oil of Thymus vulgaris L and its concomitant action with amphotericin B

Uma, B.; Prabhakar, K.; Rajendran, S., 2010:
Anticandidal Activity of Asparagus racemosus

Tayel, A.A.; Moussa, S.; el-Tras, W.F.; Knittel, D.; Opwis, K.; Schollmeyer, E., 2011:
Anticandidal action of fungal chitosan against Candida albicans

Irshad; Shreaz, S.; Manzoor, N.; Khan, L.A.; Rizvi, M.Moshahid.A., 2011:
Anticandidal activity of Cassia fistula and its effect on ergosterol biosynthesis

Nyanzi, R.; Awouafack, M.D.; Steenkamp, P.; Jooste, P.J.; Eloff, J.N., 2015:
Anticandidal activity of cell extracts from 13 probiotic Lactobacillus strains and characterisation of lactic acid and a novel fatty acid derivative from one strain

Shreaz, S.; Sheikh, R.A.; Rimple, B.; Hashmi, A.Adil.; Nikhat, M.; Khan, L.A., 2010:
Anticandidal activity of cinnamaldehyde, its ligand and Ni(II) complex: effect of increase in ring and side chain

Khan, N.; Shreaz, S.; Bhatia, R.; Ahmad, S.Imran.; Muralidhar, S.; Manzoor, N.; Khan, L.Ahmad., 2012:
Anticandidal activity of curcumin and methyl cinnamaldehyde

Celik, A.; Ergin, C.; Arslan, I.; Kartal, T., 2010:
Anticandidal activity of endemic Salvia potentillifolia Boiss. and Heldr. ex Bentham and Origanum hypericifolium Schwartz and P.H. Davis in Turkey

Sanjenbam, P.; Gopal, J.V.; Kannabiran, K., 2016:
Anticandidal activity of silver nanoparticles synthesized using Streptomyces sp.VITPK1

Işcan, Gökalp.; Köse, Y.Bülent.; Demirci, Bül.; Başer, K.Hüsnü.Can., 2012:
Anticandidal activity of the essential oil of Nepeta transcaucasica Grossh

Saad, A.; Fadli, M.; Bouaziz, M.; Benharref, A.; Mezrioui, N-E.; Hassani, L., 2011:
Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol

Geweely, N.S., 2009:
Anticandidal cytotoxicity, antitumor activities, and purified cell wall modulation by novel Schiff base ligand and its metal (II) complexes against some pathogenic yeasts

Amber, K.; Aijaz, A.; Immaculata, X.; Luqman, K.A.; Nikhat, M., 2010:
Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole

Baltch, A.L.; Bopp, L.H.; Smith, R.P.; Ritz, W.J.; Michelsen, P.B., 2008:
Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes

Shetty, P.J.; Hegde, V.; Gomes, L., 2014:
Anticandidal efficacy of denture cleansing tablet, Triphala, Aloe vera, and Cashew leaf on complete dentures of institutionalized elderly

de León, P.Gómez.; Díaz García, F.Javier.; Arredondo, J.Luis.; Segura, J.; Cerezo, S.Giono.; Santos, J.I., 2007:
Anticapsular polysaccharide IgG concentrations in Mexican children formerly immunized with Haemophilus influenzae b PRP-T vaccine

Muller, P.C.E.Hissink.; Anink, J.; Shi, J.; Levarht, E.W.N.; Reinards, T.H.C.M.; Otten, M.H.; van Tol, M.J.D.; Jol-van der Zijde, C.M.; Brinkman, D.M.C.; Allaart, C.F.; Hoppenreijs, E.P.; Koopman-Keemink, Y.; Kamphuis, S.S.M.; Dolman, K.; van den Berg, J.M.; van Rossum, M.A.J.; van Suijlekom-Smit, L.W.A.; Schilham, M.W.; Huizinga, T.W.J.; Toes, R.E.M.; Ten Cate, R.; Trouw, L.A., 2014:
Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients

Malickova, K.; Lakatos, P.L.; Bortlik, M.; Komarek, V.; Janatkova, I.; Lukas, M., 2010:
Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort

Gopalakrishnan, A.; Tony Kong, A-Ng., 2007:
Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells

Iigo, M.; Alexander, D.B.; Long, N.; Xu, J.; Fukamachi, K.; Futakuchi, M.; Takase, M.; Tsuda, H., 2008:
Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine

Manwaring, W.H., 1947:
Anticarcinogenic Serum

Bespalov, V.G.; Alexandrov, V.A.; Semenov, A.L.; Kovan'Ko, E.G.; Ivanov, S.D., 2015:
Anticarcinogenic activity of alpha-difluoromethylornithine, ginseng, eleutherococcus, and leuzea on radiation-induced carcinogenesis in female rats

Firdous, A.Pararikkal.; Sindhu, E.Raghavan.; Ramnath, V.; Kuttan, R., 2014:
Anticarcinogenic activity of meso-zeaxanthin in rodents and its possible mechanism of action

Ghosh, A.; Ghosh, D.; Sarkar, S.; Mandal, A.K.; Thakur Choudhury, S.; Das, N., 2012:
Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats

Sahpazidou, D.; Geromichalos, G.D.; Stagos, D.; Apostolou, A.; Haroutounian, S.A.; Tsatsakis, A.M.; Tzanakakis, G.N.; Hayes, A.Wallace.; Kouretas, D., 2014:
Anticarcinogenic activity of polyphenolic extracts from grape stems against breast, colon, renal and thyroid cancer cells

Sen, A.; Atmaca, P.; Terzioglu, G.; Arslan, S., 2014:
Anticarcinogenic effect and carcinogenic potential of the dietary phenolic acid: o-coumaric acid

Saraswati, S.; Alhaider, A.A.; Agrawal, S.S., 2014:
Anticarcinogenic effect of brucine in diethylnitrosamine initiated and phenobarbital-promoted hepatocarcinogenesis in rats

Bespalov, V.G.; Aleksandrov, V.A., 2013:
Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors

Kumar, M.; Verma, V.; Nagpal, R.; Kumar, A.; Behare, P.V.; Singh, B.; Aggarwal, P.K., 2012:
Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B₁-induced liver carcinogenesis in rats

Jung, M.; Bu, S.Young.; Tak, K-Hee.; Park, J-Eun.; Kim, E., 2013:
Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer

Samarghandian, S.; Borji, A., 2014:
Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients

Agrawal, R.C.; Jain, R.; Raja, W.; Ovais, M., 2009:
Anticarcinogenic effects of Solanum lycopersicum fruit extract on Swiss albino and C57 Bl mice

Noratto, G.D.; Bertoldi, M.C.; Krenek, K.; Talcott, S.T.; Stringheta, P.C.; Mertens-Talcott, S.U., 2010:
Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties

Jang, H-Jai.; Han, I-Ho.; Kim, Y-Joo.; Yamabe, N.; Lee, D.; Hwang, G.Seo.; Oh, M.; Choi, K-Chul.; Kim, S-Nam.; Ham, J.; Eom, D-Woon.; Kang, K.Sung., 2014:
Anticarcinogenic effects of products of heat-processed ginsenoside Re, a major constituent of ginseng berry, on human gastric cancer cells

Enayat, S.; Ceyhan, Müşerref.Şeyma.; Başaran, A.Ahmet.; Gürsel, M.; Banerjee, S., 2014:
Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: involvement of Akt/PKB and MAPK pathways

Norazalina, S.; Norhaizan, M.E.; Hairuszah, I.; Norashareena, M.S., 2010:
Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats

Bukowska, A., 2011:
Anticarcinogenic role of melatonin--potential mechanisms

Friedman, M., 2014:
Anticarcinogenic, cardioprotective, and other health benefits of tomato compounds lycopene, α-tomatine, and tomatidine in pure form and in fresh and processed tomatoes

Marie, I.; Jouen, F.; Hellot, M-F.; Levesque, H., 2007:
Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis

Zimmermann-Górska, I.; Grodecka-Gazdecka, S.; Białkowska-Puszczewicz, G.; Puszczewicz, M.; Goździecka, M.; Kondarewicz, Pł., 2008:
Anticardiolipin and anti-beta2 glycoprotein-1 antibodies patients with breast carcinoma: a pilot study

Devreese, K.M.J.; Van Hoecke, F., 2012:
Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays

Habibagahi, Z.; Nazarinia, M.Ali.; Aflaki, E.; Rajaee, A., 2007:
Anticardiolipin and antibeta2glycoproteinI antibodies in patients with hepatitis B and C infections

Mohammed, S.Nima.; Mousawy, K.M.; AL Bayati, A.Kamel.Muhammed.; Shawki, H.B.; Ghanim, N., 2008:
Anticardiolipin and antiphospholipid antibodies in Iraqi patients with angina pectoris

DaCosta, V.; Chin, L.; Wynter, S.; Harriott, J.; Christie, L.; Frederick-Johnston, S.; Frederick, J.; McKenzie, C.; Everett, D.; Foster, R.; Walters, Y.; Pottinger, A., 2013:
Anticardiolipin antibodies and lupus anticoagulants among women undergoing in vitro fertilization in Jamaica

Ma, J.; Zhang, C-fen.; Dong, F-tian.; Zhong, Y., 2007:
Anticardiolipin antibodies and ocular diseases

Clark, C.A.; Laskin, C.A.; Spitzer, K.A., 2013:
Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence

Homayoon, N.; Schwingenschuh, P.; Hofer, E.; Katschnig-Winter, P.; Schmidt, R., 2014:
Anticardiolipin antibodies are associated with cognitive dysfunction in stroke-free individuals

Anonymous , 2010:
Anticardiolipin antibodies are associated with epileptic seizure frequency

de Godoy, Jé.Maria.Pereira.; de Godoy, M.Fernandes.; Braile, D.Marcolino., 2008:
Anticardiolipin antibodies associated with alcoholic cardiomyopathy

Martinez, Vérie.; Diemert, M-Claude.; Braibant, M.; Potard, Vérie.; Charuel, J-Luc.; Barin, F.; Costagliola, D.; Caumes, E.; Clauvel, J-Pierre.; Autran, B.; Musset, L., 2008:
Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation

Ozmen, S.; Danis, R.; Akin, D.; Batun, S., 2009:
Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure

Skare, T.Laroka.; Ribas, C.Autralia.Paredes.Marcondes.; Malafaia, O.; Ribas Filho, J.Marcondes.; Nassif, P.Afonso.Nunes.; Nascimento, M.Mazza.do.; Fonseca, Vícius.Ribas.Carvalho.Duarte., 2010:
Anticardiolipin antibodies in leg ulcers

Loncar, D., 2010:
Anticardiolipin antibodies in pathogenesis of infertility

Zivkovic, M.; Zlatanovic, M.; Zlatanovic, G.; Djordjevic-Jocic, J.; Cekic, S., 2011:
Anticardiolipin antibodies in patients with Behcet's disease

Calvo-Romero, Jé.María.; Lima-Rodríguez, E.María., 2009:
Anticardiolipin antibodies in patients with type 2 diabetes mellitus

Anonymous, 2009:
Anticardiolipin antibodies in patients with venous thromboembolic disease from a Spanish rural area

Shahin, M.; El-Diasty, A.M.; Mabed, M., 2009:
Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor

Ali, H.A.; Osman, R.R.; Idris, M.N.; Sokrab, T-Eldin.O., 2007:
Anticardiolipin antibodies in stroke patients in Sudan. Appraisal of their significance in a region of high burden of endemic infections

Hokama, Y.; Campora, C.Empey.; Hara, C.; Kuribayashi, T.; Le Huynh, D.; Yabusaki, K., 2009:
Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome

Lioger, B.; Debiais, S.; Lauvin, M.A.; Bonnaud, I.; Maillot, F.; Ferreira-Maldent, N., 2014:
Anticardiolipin antibodies-associated stroke in primary CMV infection

Raby, A.; Moffat, K.; Crowther, M., 2013:
Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays

Giacaman, R.A.; Contzen, M.P.; Yuri, J.A.; Muñoz-Sandoval, C., 2014:
Anticaries effect of an antioxidant-rich apple concentrate on enamel in an experimental biofilm-demineralization model

Xie, Q.; Li, J.; Zhou, X., 2008:
Anticaries effect of compounds extracted from Galla chinensis in a multispecies biofilm model

Delbem, A.Carlos.Botazzo.; Bergamaschi, Mício.; Rodrigues, E.; Sassaki, K.Takebayashi.; Vieira, A.Elisa.de.Mello.; Missel, E.Macario.Coimbra., 2012:
Anticaries effect of dentifrices with calcium citrate and sodium trimetaphosphate

Heifetz, S.B.; Yaari, A.; Proskin, H., 2007:
Anticaries effectiveness of a fluoride and nonfluoride sealant

Moi, G.Pedroso.; Tenuta, Lívia.Maria.Andaló.; Cury, J.Aparecido., 2008:
Anticaries potential of a fluoride mouthrinse evaluated in vitro by validated protocols

Faller, R.V.; Eversole, S.L.; Yan, J., 2011:
Anticaries potential of a stabilized stannous-containing sodium fluoride dentifrice

Casals, E.; Boukpessi, T.; McQueen, C.M.; Eversole, S.L.; Faller, R.V., 2007:
Anticaries potential of commercial dentifrices as determined by fluoridation and remineralization efficiency

Faller, R.V.; Casey, K.; Amburgey, J., 2011:
Anticaries potential of commercial fluoride rinses as determined by fluoridation and remineralization efficiency

Téllez, Ní.; Téllez, M.; Perdomo, M.; Alvarado, A.; Gamboa, F., 2011:
Anticariogenic activity of the active fraction from Isertia laevis against S. mutans and S. sobrinus: comparison of two extraction methods

Thneibat, A.; Fontana, M.; Cochran, M.A.; Gonzalez-Cabezas, C.; Moore, B.Keith.; Matis, B.A.; Lund, M.R., 2008:
Anticariogenic and antibacterial properties of a copper varnish using an in vitro microbial caries model

Miura, K.Katsue.; Ito, I.Yoko.; Enoki, C.; Elias, A.Maria.; Matsumoto, Mírian.Aiko.Nakane., 2007:
Anticariogenic effect of fluoride-releasing elastomers in orthodontic patients

Mickenautsch, S.; Yengopal, V., 2012:
Anticariogenic effect of xylitol versus fluoride - a quantitative systematic review of clinical trials

Delbem, A.Carlos.Botazzo.; Tiano, G.Carlos.; Alves, K.Mirela.Ribeiro.Pinto.; Cunha, R.Frederico., 2006:
Anticariogenic potencial of acidulate solutions with low fluoride concentration

Severiano, M.E.; Simão, Mília.R.; Porto, T.S.; Martins, C.H.G.; Veneziani, R.C.S.; Furtado, N.A.J.C.; Arakawa, N.S.; Said, S.; de Oliveira, Déia.C.R.; Cunha, W.R.; Gregório, L.E.; Ambrósio, Sérgio.R., 2011:
Anticariogenic properties of ent-pimarane diterpenes obtained by microbial transformation

Llena, C.; Forner, L.; Baca, P., 2009:
Anticariogenicity of casein phosphopeptide-amorphous calcium phosphate: a review of the literature

Schricker, T.; Meterissian, S.; Lattermann, R.; Adegoke, O.A.J.; Marliss, E.B.; Mazza, L.; Eberhart, L.; Carli, F.; Nitschman, E.; Wykes, L., 2009:
Anticatabolic effects of avoiding preoperative fasting by intravenous hypocaloric nutrition: a randomized clinical trial

Ohno, Y.; Shimizu, S.; Imaki, J.; Ishihara, S.; Sofue, N.; Sasa, M.; Kawai, Y., 2008:
Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens

Champatisingh, D.; Sahu, P.K.; Pal, A.; Nanda, G.S., 2011:
Anticataleptic and antiepileptic activity of ethanolic extract of leaves of Mucuna pruriens: A study on role of dopaminergic system in epilepsy in albino rats

Wang, H.; Chen, X-Yi.; Chen, W-Fang.; Xue, Y.; Wei, L.; Chen, L., 2014:
Anticataleptic effects of 5-HT(1B) receptors in the globus pallidus